Global Type 1 Sbs If Short Bowel Syndrome With Intestinal Failure Treatment Market
Tamaño del mercado en miles de millones de dólares
Tasa de crecimiento anual compuesta (CAGR) :
% 
USD
1.02 Billion
USD
1.71 Billion
2025
2033
 Período de pronóstico |
2026 –2033 |
 Tamaño del mercado (año base) |
USD 1.02 Billion |
 Tamaño del mercado (año de pronóstico) |
USD 1.71 Billion |
 Tasa de crecimiento anual compuesta (CAGR) |
% |
| Jugadoras de los principales mercados |
|
Global Tipo 1 SBS-IF (Short Bowel Syndrome with Intestinal Failure), Por Modalidad de Tratamiento (Nutritional Support Therapy, Pharmacological Therapy, Surgical & Interventional Treatment, and Emerging & Advanced Therapies), por Market Attribution (Core SBS-IF Market, SBS-IF
Tipo 1 SBS-IF (Síndrome del intestino corto con falla intestinal)Tamaño
El tamaño del mercado del tipo 1 SBS-IF (síndrome del intestino delgado con falla intestinal) fue valoradoUSD 1.02 Billón en 2025y se espera que alcanceUSD 1,71 Billion by 2033, en unaCAGR of 7.3%durante el período previsto. El mercado está presenciando un crecimiento constante debido a la creciente prevalencia del síndrome de intestino corto asociado con insuficiencia intestinal, la creciente conciencia de los trastornos gastrointestinales raros y los avances continuos en terapias nutricionales y farmacológicas especializadas. La creciente adopción de enfoques multidisciplinarios de tratamiento, junto con mejores capacidades de diagnóstico y mejores estrategias de gestión de pacientes, está apoyando aún más la expansión del mercado.
La creciente carga de las reseecciones intestinales como la enfermedad de Crohn, la isquemia mesentérica, el trauma, las anomalías congénitas y las cirugías relacionadas con el cáncer ha contribuido significativamente a la demanda de tratamientos tipo 1 SBS-IF. Los proveedores de atención médica están utilizando cada vez más la nutrición parenteral, el apoyo nutricional entral y las terapias analógicas del péptido-2 (GLP-2) para mejorar la adaptación intestinal, reducir las complicaciones y mejorar la calidad de vida del paciente.
Principales tendencias del mercado "Análisis
- América del Norte dominaba el mercado de tratamiento tipo 1 SBS-IF (Síndrome de Short Bowel con falla intestinal) con la mayor cuota de ingresos del 41,37% en 2025, con el apoyo de infraestructuras sanitarias avanzadas, políticas fuertes de reembolso y acceso generalizado a centros especializados de rehabilitación intestinal.
- El segmento de la Terapia de Apoyo Nutricional llevó al mercado con un 41,93% de participación en 2025, impulsado por su papel crítico en el mantenimiento de la hidratación, la absorción de nutrientes y la gestión general del paciente durante la recuperación intestinal.
- Se espera que Asia-Pacífico sea la región de más rápido crecimiento en una CAGR de 8,0% de 2026 a 2033, alimentada por la mejora de la accesibilidad de la salud, el aumento de la conciencia de los trastornos gastrointestinales raros y la creciente inversión en opciones de tratamiento avanzadas en las economías emergentes.
- Las terapias emergentes y avanzadas son el segmento de la modalidad de tratamiento más rápido, proyectado para registrar un CAGR del 7,7%, lo que refleja una creciente adopción de biológicos innovadores, análogos GLP-2 y enfoques de tratamiento regenerativo dirigidos a reducir la dependencia de nutrición parenteral a largo plazo.
- El segmento Core SBS-IF Market dominaba la categoría de atribución del mercado con una cuota de ingresos del 56,73% en 2025, con el apoyo de la población paciente sustancial que requería una gestión de falla intestinal especializada y continua.
- El segmento de fase aguda (Tipo 1 SBS-IF) representó la mayor parte de 48.47% en 2025, impulsado por la necesidad inmediata de apoyo nutricional intensivo, manejo de fluidos e intervención clínica después de la resección o lesión intestinal principal.
- Se prevé que el segmento de fase de adaptación sea la categoría de fase de mayor crecimiento, registrando un CAGR del 7,6% durante el período de previsión, debido a la creciente concentración en terapias que mejoran la adaptación intestinal, mejoran la absorción de nutrientes y apoyen la recuperación de pacientes a largo plazo.
Tamaño del mercado
- Valor mundial del mercado (2025): 1.12 millones de dólares
- Valor de mercado esperado (2033): USD 1.71 billón
- CAGR prefabricado (2026–2033): 7,3%
- Región líder en 2025: América del Norte
- Región de crecimiento más rápida: Asia-Pacífico
Ámbito de presentación de informesTipo 1 SBS-IF mercado de tratamiento
|
Atributos |
Tipo 1 SBS-IF tratamiento claveMarket Insights |
|
Segmentos cubiertos |
|
|
Países cubiertos |
América del Norte · Estados Unidos. · Canadá · México Europa · Alemania · Francia · U.K. · Países Bajos Suiza · Bélgica · Rusia · Italia · España · Turquía · El resto de Europa Asia y el Pacífico China · Japón · India · Corea del Sur · Singapur Malasia · Australia · Tailandia · Indonesia · Filipinas · El resto de Asia-Pacífico Oriente Medio y África Arabia Saudita · EAU. · Sudáfrica Egipto Israel · El resto del Oriente Medio y África América del Sur Brasil · Argentina · El resto de Sudamérica |
|
Principales jugadores del mercado |
· Takeda Pharmaceutical Company Limited (Japón) · Fresenius Kabi AG (Alemania) · Baxter International Inc. (U.S.) · Nestlé Health Science (Suiza) · Laboratorios Abbott (U.S.) · Zelanda Pharma A/S (Dinamarca) · Hanmi Pharm. Co., Ltd. (Corea del Sur) · OxThera (Suecia) · AmeriPharma Specialty Care (U.S.) · ContinuumRx (U.S.) · Terapia Napo (Suiza) · Regenesis de Eclipse (U.S.) · AcuLife Healthcare Private Limited (India) · Ferring Pharmaceuticals (Suiza) · Shandong Qidu Pharmaceutical Co., Ltd. (China) · Elección de la Nutrición Parenteral LLC (U.S.) · Sistemas Integrados de Atención (U.S.) · Beverly Hills Digestive Care (U.S.) · Stanford Health Care (U.S.) · Visión Parenteral (U.S.) · Amsino International, Inc. (U.S.) · Atención de la salud aguda (India) · Nutrego (Países Bajos) · Camvitaa (India) · Laboratoire Dielen (Francia) · Soluciones de infusión (U.S.) · Cuidado de Salud Aurora (EE.UU.) |
|
Oportunidades de mercado |
· Avances en Medicina Regenerativa · Ampliación de la atención nutricional en el hogar |
|
Valor añadido Data Infosets |
Además de las ideas sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado comisariados por Data Bridge Market Research también incluyen análisis profundos de expertos, epidemiología de pacientes, análisis de tuberías, análisis de precios y marco regulatorio. |
Tipo 1 SBS-IF (Síndrome del intestino corto con falla intestinal)
Tendencia: Manejo multidisciplinario complejo de pacientes
Los avances en la medicina regenerativa y la rehabilitación intestinal están creando fuertes oportunidades de crecimiento para el mercado global de tratamiento SBS-IF. Los investigadores y las instituciones sanitarias se centran cada vez más en terapias que pueden mejorar la adaptación intestinal, regenerar el tejido intestinal dañado y reducir la dependencia a largo plazo de la nutrición parenteral. Según estudios apoyados por los Institutos Nacionales de Salud, enfoques regenerativos como terapia de células madre, ingeniería de tejidos e investigación de trasplantes intestinales están mostrando resultados prometedores para mejorar la absorción de nutrientes y restaurar la función intestinal en pacientes SBS-IF severos. Varios hospitales académicos y centros especializados de rehabilitación intestinal en América del Norte y Europa también están ampliando programas multidisciplinarios de tratamiento que combinan terapias GLP-2, apoyo nutricional avanzado, cirugía y planes de rehabilitación personalizados. Estos desarrollos están ayudando a mejorar la supervivencia del paciente y la calidad de vida a la vez que se abren nuevas oportunidades de tratamiento a largo plazo más allá de la gestión nutricional tradicional.
Tipo 1 SBS-IF (Síndrome del intestino corto con falla intestinal) Dinámica del mercado de tratamiento
Conductor del mercado clave: aumento del SBS-Si la población del paciente
La creciente población paciente que sufre de síndrome de Short Bowel con falla intestinal (SBS-IF) se está convirtiendo en uno de los principales factores de crecimiento para el mercado global de tratamiento. SBS-IF se desarrolla principalmente cuando una gran parte del intestino delgado se elimina a través de la cirugía, reduciendo la capacidad del cuerpo para absorber nutrientes y líquidos adecuadamente. Según el National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), la afección ocurre más comúnmente después de pequeñas cirugías de resección intestinal realizadas para enfermedades como la enfermedad de Crohn, cánceres intestinales, traumatismo, obstrucción intestinal, isquemia y trastornos intestinales congénitos. La creciente incidencia de enfermedades inflamatorias intestinales, especialmente la enfermedad de Crohn, contribuye significativamente al aumento de las cirugías intestinales en todo el mundo. NIDDK también afirma que los pacientes con enfermedad severa de Crohn a menudo requieren reseecciones de intestino repetidas, lo que aumenta el riesgo a largo plazo de desarrollar SBS-IF.
Restricción clave / desafío: alto costo de SBS-Si el tratamiento
El alto costo del tratamiento SBS-IF sigue siendo una de las mayores restricciones para el mercado global de tratamiento tipo 1 SBS-IF. Los pacientes con síndrome del intestino corto con insuficiencia intestinal a menudo requieren nutrición parenteral permanente, monitoreo hospitalario frecuente, rehabilitación intestinal especializada y terapias biológicas avanzadas como teduglutida. Según la información de tratamiento de EE.UU. Food and Drug Administration y Takeda, las terapias GLP-2 como GATTEX pueden costar casi USD 400.000–USD 500.000 al año por paciente en los Estados Unidos, haciendo que el tratamiento sea financieramente difícil para muchas familias y sistemas de salud. Además de los costos de los fármacos, los pacientes con SBS-IF a menudo necesitan atención central de catéter venoso, suplementos nutricionales, pruebas regulares de sangre y reincidencias hospitalarias debido a infecciones o complicaciones de deshidratación. Estos gastos médicos a largo plazo suponen una carga importante tanto para los pacientes como para los proveedores de seguros, especialmente en los países donde la cobertura de reembolso por enfermedades raras sigue siendo limitada.
Oportunidad del mercado clave: Ampliación de terapias analógicas avanzadas y GLP-2.
El mercado global de tratamiento tipo 1 SBS-IF presenta importantes oportunidades de crecimiento impulsadas por avances continuos en enfoques de manejo terapéutico y nutricional. Aumentar la adopción de nuevas tecnologías biológicas, en particular las terapias analógicas GLP-2, está creando nuevas vías para mejorar la adaptación intestinal y reducir la dependencia de la nutrición parenteral. El enfoque cada vez mayor en los planes de nutrición personalizados y la atención multidisciplinaria es mejorar los resultados de los pacientes y ampliar la accesibilidad al tratamiento. Las economías emergentes ofrecen un potencial considerable debido a la mejora de la infraestructura sanitaria, una mayor conciencia de los trastornos gastrointestinales raros y el aumento del gasto sanitario. Además, la investigación en curso en medicina regenerativa, terapias basadas en células madre e ingeniería de tejido intestinal puede transformar futuros paradigmas de tratamiento. También se espera que la ampliación de los modelos de atención en el hogar y las soluciones de control remoto mejoren la gestión de enfermedades a largo plazo y la calidad de vida de los pacientes.
Tipo 1 SBS-IF mercado de tratamiento
El mercado de tratamiento tipo 1 SBS-IF (síndrome de tazón corto con falla intestinal) se segmenta en segmentos notables basados en la modalidad de tratamiento, atribución de mercado, fase de gestión de enfermedades, tipo de paciente, ruta de administración, usuario final, canal de distribución.
- Por modalidad de tratamiento
Sobre la base de la modalidad de tratamiento, el tipo 1 SBS-IF (Síndrome del intestino delgado con falla intestinal) El mercado de tratamiento se segmenta en terapia de apoyo nutricional, terapia farmacológica, tratamiento intervencional quirúrgico y terapias avanzadas emergentes. En 2026, se espera que el segmento de terapia de apoyo nutricional domine el mercado con una proporción de 42.00% debido a la dependencia crítica de pacientes tipo 1 SBS-IF sobre rehabilitación nutricional y terapias de apoyo intestinal a largo plazo para mantener la hidratación, absorción de nutrientes y estabilidad metabólica general
Se prevé que el segmento de terapias avanzadas emergentes será testigo de la CAGR más rápida del 7,7% de 2026 a 2033, alimentada por el aumento de las actividades de investigación y desarrollo centradas en tratamientos gastrointestinales innovadores, medicina regenerativa y terapias basadas en péptidos para el síndrome de intestino corto con insuficiencia intestinal (SBS-IF). La creciente adopción de biológicas avanzadas, el aumento de las inversiones en ensayos clínicos y la creciente demanda de terapias que reducen la dependencia de la nutrición parenteral a largo plazo están acelerando aún más el crecimiento de este segmento en mercados de salud desarrollados y emergentes.
- Atribución del mercado
Sobre la base de la atribución del mercado, el tipo 1 SBS-IF (Síndrome de Short Bowel con falla intestinal) El mercado de tratamiento se segmenta en el mercado central SBS-IF, el mercado atribuible SBS-IF y el mercado adyacente/no específico. En 2026, se espera que el segmento central del mercado SBS-IF domine el mercado con 56,72% debido a la alta dependencia clínica de terapias nutricionales especializadas y tratamientos de adaptación intestinal dirigidos directamente asociados con la gestión SBS-IF.
Se espera que el segmento de mercado atribuible SBS-IF sea testigo de la CAGR más rápida del 9,5% entre 2026 y 2033, impulsada por la creciente prevalencia de insuficiencia intestinal asociada al síndrome de intestino corto y la creciente demanda de terapias de apoyo a largo plazo nutricionales y gastrointestinales. El crecimiento se apoya además en los avances en las formulaciones de nutrición parenteral, la ampliación de la disponibilidad de terapéuticas específicas y la concienciación creciente sobre el diagnóstico precoz y los enfoques de tratamiento especializados encaminados a mejorar la calidad de vida de los pacientes y reducir las tasas de hospitalización.
- Por fase de gestión de enfermedades
Sobre la base de la fase de gestión de enfermedades, el mercado de tratamiento tipo 1 SBS-IF (síndrome del intestino delgado con falla intestinal) se segmenta en fase aguda (Tipo 1 SBS-IF), fase de adaptación y fase de recuperación. En 2026, se espera que el segmento de fase aguda (Tipo 1 SBS-IF) domine el mercado con una proporción de 48,46% debido al requisito inmediato de apoyo nutricional intensivo, estabilización de fluidos y hospitalización tras disfunción intestinal o resección quirúrgica.
Se prevé que el segmento de fase de adaptación sea testigo de la CAGR más rápida del 7,6% entre 2026 y 2033, impulsada por el creciente enfoque en las terapias de rehabilitación intestinal y estrategias avanzadas de gestión nutricional destinadas a mejorar la adaptación intestinal y reducir la dependencia a largo plazo de la nutrición parenteral. El aumento de la adopción de enfoques de tratamiento personalizados, el aumento de la conciencia clínica sobre la intervención temprana y los avances continuos en la terapéutica gastrointestinales están apoyando aún más el rápido crecimiento de este segmento durante el período de pronóstico.
- Por vía administrativa
Sobre la base de la ruta de administración, el tipo 1 SBS-IF (Síndrome del Tazón corto con falla intestinal) El mercado de tratamiento se segmenta en intravenosa, subcutánea, oral y enteral. The intravenous segment is further segmented into PN and injectables. En 2026, se prevé que el segmento intravenoso dominará el mercado con una proporción del 49,45% debido a la utilización generalizada de la nutrición parenteral y las terapias administradas por el hospital en pacientes con SBS-IF con capacidad de absorción intestinal comprometida.
Se espera que el segmento subcutáneo sea testigo de la CAGR más rápida del 7,6% de 2026 a 2033, alimentada por la creciente preferencia por métodos de administración de drogas mínimamente invasivos y la creciente adopción de soluciones de tratamiento basadas en el hogar entre pacientes con SBS-IF tipo 1. Además, los avances en las formulaciones de entrega subcutáneas, la mejora de la comodidad de los pacientes, la reducción de las visitas hospitalarias y la creciente demanda de terapias de apoyo a largo plazo están acelerando aún más el crecimiento de este segmento durante el período previsto.
- Por usuario final
Sobre la base del usuario final, el mercado de tratamiento tipo 1 SBS-IF (Síndrome del intestino delgado con insuficiencia intestinal) se segmenta en hospitales (cuidado agudo), atención a domicilio (programas HPN), configuración de UCI, centros especiales de GI y hospitales de especialidades pediátricas. En 2026, se espera que el segmento de hospitales (cuidado agudo) domine el mercado con una proporción de 38,67% debido al elevado requisito de gestión multidisciplinaria de tratamiento, monitoreo intensivo de nutrición y atención gastrointestinal especializada durante la fase aguda del tratamiento SBS-IF.
Se espera que el segmento Home Care (Programas HPN) sea testigo de la CAGR más rápida del 7,9% de 2026 a 2033, alimentada por la creciente preferencia por soluciones sanitarias basadas en el hogar entre pacientes que requieren apoyo nutricional parenteral a largo plazo. El aumento de los costos de salud, los avances en las tecnologías de infusión portátiles, y el creciente énfasis en mejorar la comodidad del paciente y la calidad de vida están acelerando aún más la adopción de programas de nutrición parenteral doméstica (HPN) a nivel mundial.
- Por canal de distribución
Sobre la base del canal de distribución, el tipo 1 SBS-IF (Síndrome del intestino delgado con falla intestinal) El mercado de tratamiento se segmenta en farmacia hospitalaria, farmacia especializada, farmacia minorista y farmacia en línea. En 2026, se espera que el segmento de farmacia hospitalaria domine el mercado con una proporción de 46,37% debido al alto volumen de terapias nutricionales ambulatorias, biológicas y medicamentos inyectables administrados en entornos hospitalarios para la gestión SBS-IF.
Se espera que el segmento de Farmacia Especial sea testigo de la CAGR más rápida del 7,7% entre 2026 y 2033, alimentada por la creciente demanda de tratamiento personalizado, servicios de infusión en el hogar y terapias de apoyo nutricional a largo plazo para pacientes que sufren de tipo 1 SBS-IF. Además, la creciente adopción de servicios especializados de farmacia para la distribución eficiente de drogas, la vigilancia de los pacientes, la asistencia para el reembolso y una mejor adhesión a regímenes terapéuticos complejos está acelerando aún más el crecimiento de los segmentos durante el período previsto.
Tipo 1 SBS-IF (Síndrome del intestino delgado con falla intestinal)
América del Norte dominaba el mercado de tratamiento tipo 1 SBS-IF y representaba la mayor proporción de ingresos del 41,37% en 2025, apoyado por infraestructuras sanitarias avanzadas, marcos de reembolso favorables y la fuerte presencia de centros de rehabilitación intestinal especializados. La región se beneficia de una alta conciencia y un diagnóstico temprano del síndrome de intestino corto, una adopción generalizada de nutrición parenteral y terapias farmacológicas avanzadas, e importantes inversiones en investigación de enfermedades raras. Además, la disponibilidad de tratamientos biológicos innovadores, la actividad de ensayo clínico robusta y el firme apoyo reglamentario para los medicamentos huérfanos han contribuido al crecimiento del mercado. El aumento de la atención en la mejora de los resultados de los pacientes, la reducción de las complicaciones a largo plazo asociadas con el fracaso intestinal, y la ampliación del acceso a programas de atención multidisciplinar continúa fortaleciendo la posición líder en América del Norte en el mercado global de tratamiento tipo 1 SBS-IF.
U.S. Tipo 1 SBS-IF (Síndrome del intestino delgado con falla intestinal)
El mercado de tratamiento U.S. Tipo 1 SBS-IF (Short Bowel Syndrome with Intestinal Failure) representa la mayor parte del mercado norteamericano, impulsado por instalaciones sanitarias avanzadas, una fuerte cobertura de reembolso y una amplia disponibilidad de programas especializados de rehabilitación intestinal. El aumento de la adopción de nutrición parenteral, terapias innovadoras GLP-2 y iniciativas de investigación de enfermedades raras en curso siguen apoyando el crecimiento del mercado y mejorando los resultados de los pacientes.
Europa Tipo 1 SBS-IF (Síndrome del intestino corto con falla intestinal)
El mercado de tratamiento Europa Tipo 1 SBS-IF (Síndrome del Tazón corto con falla intestinal) está experimentando un crecimiento constante, impulsado por sistemas sanitarios bien establecidos, aumentando la conciencia de los trastornos gastrointestinales raros y la disponibilidad generalizada de servicios especializados de rehabilitación intestinal. La creciente adopción de terapias avanzadas de apoyo nutricional, políticas favorables de medicamentos huérfanos y actividades de investigación clínica en curso están apoyando la innovación en el tratamiento y mejorando los resultados de los pacientes en toda la región.
U.K. Tipo 1 SBS-IF (Síndrome del intestino delgado con falla intestinal)
El mercado de tratamiento U.K. Tipo 1 SBS-IF (Short Bowel Syndrome with Intestinal Failure) cuenta con el apoyo de un sistema sanitario bien establecido, la adopción de terapias nutricionales especializadas y el creciente acceso a servicios multidisciplinarios de rehabilitación intestinal. El aumento de la conciencia de los trastornos gastrointestinales raros, las directrices clínicas favorables y los avances en los tratamientos biológicos contribuyen a mejorar la gestión de los pacientes y el crecimiento del mercado en todo el país.
Alemania Tipo 1 SBS-IF (Síndrome del intestino delgado con falla intestinal)
Alemania representa un mercado significativo para el tratamiento tipo 1 SBS-IF (Síndrome del Tazón corto con falla intestinal), impulsado por su sistema de salud avanzado, una fuerte cobertura de reembolso y una red bien establecida de centros especializados de gastroenterología y rehabilitación intestinal. Aumentar la adopción de la nutrición parenteral, aumentar el acceso a terapias innovadoras y las actividades de investigación clínica en curso están apoyando una mejor gestión de pacientes y contribuyendo al crecimiento del mercado en todo el país.
Asia-Pacífico Tipo 1 SBS-IF (Short Bowel Syndrome with Intestinal Failure) Tratamiento Mercado Insight
Se espera que el mercado de tratamiento tipo 1 SBS-IF de Asia-Pacífico sea testigo del crecimiento más rápido, registrando una CAGR durante el período de previsión. El crecimiento está impulsado por mejorar la infraestructura sanitaria, aumentar la conciencia de los trastornos gastrointestinales raros, ampliar el acceso a terapias nutricionales especializadas y aumentar el gasto sanitario. Países como China, Japón, India y Corea del Sur están invirtiendo en opciones avanzadas de tratamiento y servicios de rehabilitación intestinal, apoyando la expansión del mercado en toda la región.
Japón Tipo 1 SBS-IF (Síndrome del intestino delgado con falla intestinal)
El mercado de tratamiento Japón tipo 1 SBS-IF (síndrome del intestino delgado con insuficiencia intestinal) está presenciando un crecimiento constante debido al sistema de salud avanzado del país, aumentando la prevalencia de trastornos gastrointestinales que requieren resección intestinal y un fuerte enfoque en la gestión de enfermedades raras. Aumentar la adopción de terapias especializadas de apoyo nutricional, mejorar el acceso a tratamientos innovadores y ampliar los programas de rehabilitación intestinal están contribuyendo a mejorar la atención del paciente y el desarrollo del mercado.
China Tipo 1 SBS-IF (Síndrome del intestino delgado con falla intestinal)
El mercado de tratamiento China Tipo 1 SBS-IF (Short Bowel Syndrome with Intestinal Failure) está experimentando un crecimiento constante, impulsado por mejorar la infraestructura sanitaria, aumentar la conciencia de los trastornos gastrointestinales raros y ampliar el acceso a terapias de apoyo nutricional especializadas. Aumentar las inversiones en atención médica avanzada, aumentar la adopción de programas de rehabilitación intestinal y mejorar las capacidades de diagnóstico están apoyando el desarrollo del mercado. Además, los esfuerzos gubernamentales por fortalecer la gestión de enfermedades raras y la accesibilidad sanitaria están creando condiciones favorables para la adopción de enfoques innovadores de tratamiento SBS-IF.
Tipo 1 SBS-IF mercado de tratamiento Compartir
La industria de tratamiento Tipo 1 SBS-IF está dirigida principalmente por empresas bien establecidas, incluyendo:
- Takeda Pharmaceutical Company Limited (Japón)
- Fresenius Kabi AG (Alemania)
- Baxter International Inc. (U.S.)
- Nestlé Health Science (Suiza)
- Abbott Laboratories (U.S.)
- Zealand Pharma A/S (Dinamarca)
- Hanmi Pharm. Co., Ltd. (Corea del Sur)
- OxThera (Suecia)
- AmeriPharma Specialty Care (Estados Unidos)
- ContinuumRx (U.S.)
- Terapéutica Napo (Suiza)
- Eclipse Regenesis (U.S.)
- AcuLife Healthcare Private Limited (India)
- Ferring Pharmaceuticals (Suiza)
- Shandong Qidu Pharmaceutical Co., Ltd. (China)
- Elección de la Nutrición Parenteral LLC (U.S.)
- Integrated Care Systems (U.S.)
- Beverly Hills Digestive Care (Estados Unidos)
- Stanford Health Care (Estados Unidos)
- Vision Parenteral (U.S.)
- Amsino International, Inc. (U.S.)
- Aculife Healthcare (India)
- Nutrego (Países Bajos)
- Camvitaa (India)
- Laboratoire Dielen (Francia)
- Infusion Solutions (U.S.)
- Aurora Health Care (U.S.)
Novedades en el tipo 1 SBS-IF (Síndrome del intestino corto con falla intestinal)
- En 2026, Takeda Pharmaceutical Company Limited continuó expandiendo su enfermedad gastrointestinal y su raro trastorno portafolio terapéutico a través de inversiones en biologics, innovación gastrointestinal y investigación avanzada del tratamiento del trastorno intestinal, reforzando su posición estratégica a largo plazo en el mercado de tratamiento Tipo 1 SBS-IF (Short Bowel Syndrome with Intestinal Failure).
- En 2026, Abbott Laboratories siguió centrándose en soluciones avanzadas de nutrición clínica y atención gastrointestinal mediante la innovación continua en formulaciones nutricionales especializadas y terapias de apoyo nutricional basadas en hospitales, fortaleciendo su posición en el mercado de tratamiento tipo 1 SBS-IF (Short Bowel Syndrome with Intestinal Failure).
- En marzo de 2026, Nestlé Health Science introdujo soluciones innovadoras de nutrición médica y fortaleció su estrategia de integración de la nutrición y la salud para ampliar su cartera de nutrición clínica y salud gastrointestinal, apoyando oportunidades de crecimiento en el mercado de tratamiento Tipo 1 SBS-IF (Short Bowel Syndrome with Intestinal Failure). 2026, Unilever anunció la adquisición de la marca de suplementos estadounidenses Grüns para ampliar su cartera de bienestar y salud. Este desarrollo fortalece la posición de Unilever en los crecientes segmentos nutracéuticos y cosmecéuticos.
- En abril de 2026, Baxter International mostró innovaciones recientes en la AORN Global Surgical Conference " Expo 2026 y continuó ampliando su cartera de servicios nutricionales y tecnologías sanitarias conectadas, reforzando su presencia en soluciones de atención crítica y tratamiento relacionadas con SBS-IF.
- En abril de 2026, Fresenius Kabi AG destacó su amplia cartera de nutrición clínica y terapia de infusión mediante inversiones continuas en tecnologías avanzadas de salud y soluciones de tratamiento biológico, fortaleciendo su posición en el mercado de tratamiento tipo 1 SBS-IF (Short Bowel Syndrome with Intestinal Failure).
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
1 INTRODUCCIÓN
1.1 OBJETIVOS DEL ESTUDIO
1.2 DEFINICIÓN DEL MERCADO
1.3 Revisión general del TYPE GLOBAL 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITACIONES
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 ÁMBIÉN GEOGRÁFICO
2.3 AÑOS ESTUDIOS PARA EL ESTUDIO
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 ENTREVISTAS PRIMARÍAS CON LEADRES DE OPINION KEY
2.6 GRID DE POSICIÓN DEL MERCADO
2.7 VENDOR SHARE ANALISIS
2.8 MULTIVARIATE MODELING
2.9 CURVE DE TIPO DE PRODUCTOS
2.1 MARKET APPLICATION GRID
2.11 FUERZAS SEGUNDARIAS
2.12 ASUNTOS
RESUMEN EJECUTIVO
4 fotos INSIGHTS
4.1 ANÁLISIS PESTEL
4.1.1 INTRODUCCIÓN
4.1.2 ANÁLISIS POLÍTICO
4.1.3 ANÁLISIS ECONÓMICO
4.1.4 ANÁLISIS SOCIAL
4.1.5 ANÁLISIS TECNOLOGICO
4.1.6 ANÁLISIS AMBIENTE
4.1.7 ANÁLISIS JURÍDICO
4.1.8 CONCLUSIÓN
4.2 FIVE FORCES DE PORTER
4.2.1 INTRODUCCIÓN
4.2.2 INTENSITY OF COMPETITIVE RIVALRY (HIGH)
4.2.3 POWER BARGAINING POWER OF BUYERS – ALTO
4.2.4 Tres de los nuevos territorios - MODERATE
4.2.5 THREAT OF SUBSTITUTE PRODUCTS – MODERATE
4.2.6 BARGAINING POWER OF SUPPLIERS – MODERATE
4.2.7
4.3 QUADRANT DE EVALUACIÓN DE EMPRESAS
4.4 METODOLOGÍA DEL FONDO PACTO (MODEL DE MANDATORIA)
4.4.1 Un FONDO PACIENTE DE BOTTOM-UP será CONSTRUCIDO
4.4.1.1 POBLACIÓN TOTAL DE SBS
4.4.1.2 POBLACIÓN SBS-IF
4.4.1.3 DIAGNOSED SBS-IF PATIENTS
4.4.1.4 PACIENTES TREATED SBS-IF
4.4.1.5 POOLAS PACIENTES THERAPY-SPECIFIC
4.4.1.6 ESTE ENSURES PATIENT NUMBERS are DIRECTLY ESTIMATED, NO INFERREDED from MARKET SIZE
4.4.1.7 GLOBAL PATIENT FUNNEL SEGMENTATION
4.4.1.8 POBLACIÓN TOTAL DE SBS
4.4.1.9 SBS ADULT
4.4.1.10 PEDIATRIC SBS
4.4.1.11 POBLACIÓN SBS-IF
4.4.1.12 TYPE 1 SBS-IF (ACUTE)
4.4.1.13 TYPE 2 SBS-IF (PROLONGED ACUTE)
4.4.1.14 TYPE 3 SBS-IF (CHRONIC)
4.4.1.15 POBLACIÓN DIAGNOSADA
4.4.1.16 DIAGNOSED – HOSPITAL-BASED
4.4.1.17 DIAGNOSED – OUTPATIENT
4.4.1.18 UNDIAGNOSED / MISCLASSIFIED
4.4.1.19 POBLACIÓN PACIENTE TREATED
4.4.1.20 PACIENTES TREATEDES
4.4.1.21
4.4.2 TREATMENT-SPECIFIC PATIENT SEGMENTATION (CRITICAL)
4.4.2.1 POPULACIÓN PACIENTE PN-DEPENDIENTO (SEGMENTO DE CORE)
4.4.2.2 FULLY PN-DEPENDENT
4.4.2.3 PARTIALLY PN-DEPENDENT
4.4.2.4 UCI PN-DEPENDENT (TYPE 1 ACUTE)
4.4.2.5 HOME PN-DEPENDENT
4.4.2.6 GLP-2 ANALOGUE TREATED PATIENTS
4.4.2.7 INCLUYEN LOS PACIENTES RECIBIDAS
4.4.2.8 PIPELINE THERAPIES (E.G., APRAGLUTIDE)
4.4.2.9
GLP-2
4.4.2.11 PN-WEANING PATIENTS
4.4.2.12 PEDIATRIC VS ADULT
4.4.2.13 PHARMACOTHERAPY PATIENTS (ATTRIBUTABLE)
4.4.2.14 USUARIOS ANTI-DIARRHEAL
4.4.2.15
4.4.2.16 ANTIBIOTIC (SIBO) PACIENTES
4.4.2.17 MICRONUTRIENT-DEPENDENT PATIENTS
4.4.2.18 PACIENTES SURGICOS Y TRANSPLANTES
4.4.2.19 PROCEDIMIENTOS DE LENGTHENAL
4.4.2.20 PACIENTES TRANSPLANTES
4.4.2.21 SURVIVORS POST-TRANSPLANT
4.4.3 SEGMENTACIÓN PACIENTE POR DEPENDENCY STATUS (HIGHLY IMPORTANT)
POPULACIÓN PN-DEPENDIEN
4.4.3.2 SEGUIMIENTO DE LA REVENCIÓN DE LOS PAÍSES
4.4.3.3 POPULACIÓN DE PNBANING
4.4.3.4 RESPONDERS GLP-2
POPULACIÓN PN-INDEPENDENT
4.4.3.6 MAINTAINED ON ORAL/ENTERAL THERAPY
4.4.4 SEGMENTACIÓN PACIENTE POR FASE DISEÑO (TYPE 1 FOCUS)
4.4.4.1 ACUTE PHASE (TYPE 1 SBS-IF)
4.4.4.2 ICU-MANAGED PATIENTS
4.4.4.3 HIGH PN UTILIZATION
4.4.4.4 FASE DE ADAPTACIÓN
4.4.4.5 TRANSICIÓN A LA NUTRICIÓN ENTERAL
4.4.4.6 INITIATION OF GLP-2 THERAPY
4.4.4.7 HABILIZACIÓN / ESTABILIZACIÓN
4.4.4.8 REDUCED PN DEPENDENCY
4.4.4.9 MANTENIMIENTO DE LOS TERMINOS
4.4.4.10 SEGMENTACIÓN PACIENTE POR CARE
4.4.4.11 PACIENTES HOSPITAL-BASED
4.4.4.12 UCID
4.4.4.13 WARDS SURGICAS
4.4.4.14 PACIENTES DE CARE
4.4.4.15 HOME PARENTERAL NUTRITION (HPN)
4.4.16 CENTROS ESPECIALES
4.4.4.17 CENTROS INTESTINALES DE REHABILITACIÓN
4.4.5 SEGMENTACIÓN PACIENTE POR LOS DEMOGRAFÍAS
4.4.5.1 GRUPO DE AGE
4.4.5.2 NEONACIONES
4.4.5.3 PEDIATRIC
4.4.5.4
4.4.5.5 GERIATRIC
4.4.5.6 GENDER
4.4.5.7
4.4.5.8 FEMALE
4.4.6 SEGMENTACIÓN PACIENTE POR ETIOLOGÍA
4.4.6.1 ETIOLOGÍA ADULT
4.4.6.2 DISEÑO DE CROHN
4.4.6.3 MESENTERIC ISCHEMIA
4.4.6.4 Respuestas SURGICAS
4.4.6.5 REALIZADO DE LAS NACIONES UNIDAS
4.4.6.6 ETIOLOGÍA PEDIATRIC
4.4.6.7 NECROTIZING ENTEROCOLITIS (NEC)
4.4.6.8 DEFECTOS CONGENIALES (ATRESIA, GASTROSCHISIS)
4.4.7 DISTRIBUCIÓN PACIENTE GEOGRÁFICO
4.4.7.1 NORTH AMERICA
4.4.7.2 U.S.
4.4.7.3 CANADA
4.4.7.4 EUROPA
4.4.7.5 ALEMANIA
4.4.7.6
4.4.7.7 Reino Unido
4.4.7.8
4.4.7.9 ESPAÑA
4.4.7.10 ASIA-PAIFIC
4.4.7.11 JAPÓN
4.4.7.12 CHINA
4.4.7.13 INDIA
4.4.8 TREATMENT PENETRATION " UTILIZATION RATES
4.4.8.1 PN PENETRATION RATE
4.4.8.2 % DE PACIENTES SBS-IF EN PN
4.4.8.3 GLP-2
4.4.8.4 % DE LOS PACIENTES ELIGIBLES GLP-2
4.4.8.5 Perfeccionamiento de la Terapia
4.4.8.6 ANTI-DIARRHEAL USAGE RATE
4.4.8.7 PPI USAGE RATE
4.4.8.8 Modificación de los GASTOS PATIENT-LEVEL
4.4.8.9 Gastos anuales
4.4.8.10 PN COST (HOSPITAL VS HOME)
4.4.8.11 GLP-2 THERAPY COST
4.4.8.12 GASTOS DE ARAPACIDAD
4.4.9 COST BY PATIENT TYPE
4.4.9.1 PN-DEPENDENT
4.4.9.2 GLP-2
4.4.9.3
4.4.9.4 DELIVERABLES DELPUT (EXCEL – CLIENT CRITICAL)
4.4.9.5 PACIENTES TOTAL SBS-IF (Por país)
4.4.9.6 VS DIAGNOSED TREATED PATIENTS
4.4.9.7 PN-DEPENDENT PATIENTS
4.4.9.8 GLP-2 TREATED PATIENTS
4.4.9.
4.4.9.10 AVERAGE ANNUAL COST PER THERAPY
4.5 INSIGHTS INDUSTRY
4.5.1 INTRODUCCIÓN
4.5.2 Examen general de la estructura interna
4.5.3 MICRO Y FACTORES ECONÓMICOS MACRO
4.5.4 PENETRATION AND GROWTH PROSPECT MAPPING
4.5.5 ESTRATEGIAS PRINCIPALES
4.5.6 INTERVIEWS with SPECIALISTS
4.5.7 ANÁLISIS Y RECOMENDACIÓN
4.5.8 CONCLUSIÓN
4.6 LA DISRUPCIÓN DE LA GUERRA DE LA GUERRA DE LOS CHAINS PHARMACEUTICAS SUPPLY, GEOGRAPHIC FOOTPRINTs, STRUCTURAL CHANGES, AND ADAPTIVE STRATEGIES
INTRODUCCIÓN
4.6.2 RESULTIVAMENTE CHAIN
4.6.2.1 DIVERSIFICACIÓN DE LOS SUPLEMENTOS INGRESOS Y PN/DRUG
4.6.2.2 ESTABLECIMIENTO DE LOS HUBES DE PRODUCCIÓN REGIONAL
STRATEGIC STOCKPILING OF CRITICAL PN BAGS, GLP-2 ANALOGUES, AND MEDICAL DEVICES
4.6.2.4 DESARROLLO DE LAS LOGISTICAS ALTERNATIVAS Y LOS CHAINES COLOS
4.6.2.5 CENTROS ESTRATEGICOS CON CDMOS LEADING (E.G., CATALENT, LONZA)
4.6.2.6 EXPANSION OF MANUFACTURING, FILL-FINISH, AND PACKAGING CAPABILITIES FOR PN & GLP-2
4.6.3 ENERGÍA " MANUFACTURING OPERATIONAL COST RISK
4.6.3.1 RISING ENERGY COSTS IN PARENTERAL NUTRITION ' DRUG FACILITIES
4.6.3.2 GASTOS INCREADOS PARA MATERIALES RAW, EMULSIONES LIPID, Y PHARMACEUTICAS
4.6.3.3 ESTRATEGIAS DE PROCURACIÓN DE LA ENERGÍA ENTRE LOS PN MANUFACTURERES
4.6.3.4 APROBACIÓN DE LAS TECNOLOGÍAS DE MANUFACTURACIÓN DE ENERGÍAS
4.6.3.5 DEPLOYMENT OF ADVANCED AUTOMATION AND CONTINUOUS SYSTEMS
4.6.3.6 INTEGRACIÓN DE LA ENERGÍA RENEWABLE EN LAS FACILIDADES DE MANUFACTURACIÓN
4.6.4 Observaciones de la FOOTPRINT GEOGRAPHIC
4.6.4.1 EXPANSION OF MANUFACTURING IN STABLE REGIONS
4.6.4.2 DIVERSIFICACIÓN DE LA PRODUCCIÓN GLOBAL PN/GLP-2
4.6.4.3 RELOCACIÓN DE LA PRODUCCIÓN DE KEY INPUT/INTERMEDIATE
4.6.4.4 EXPANSION INTO EMERGING MARKETS with HIGH SBS-IF BURDEN
4.6.4.5 ESTABLECIMIENTO DE LOS HUBOS DE TRANSICIÓN Y DISTRIBUCIÓN REGIONALES
4.6.5 Plantilla SCENARIO " RISK MANAGEMENT
4.6.5.1 DESARROLLO DE PLANES DE CONTINGENCY SUPLEMENTE
4.6.5.2 ESTRATEGIAS DE PROCURACIÓN MULTI-SOURCE PARA PN/GLP-2
4.6.5.3 COLABORACIONES DE GOBIERNO Y SALUD
4.6.5.4 Redes de respuesta de la crisis para las terapias críticas
4.6.5.5 DEPLOYMENT OF PREDICTIVE SUPPLY CHAIN ANALYTICS IN SBS-IF MARKET
4.6.6 CASH " FINANCIERA PROTECCIÓN
4.6.7 RESERVAS DE CAPITAL PARA LA EXPANSIÓN PN " BIOPHARMA
4.6.7.1 DIVERSIFICACIÓN DE LOS PORFOLIOS DE PRODUCTOS Y LAS ESFERAS REVENIDAS
4.6.7.2 INVESTMENTOS EN LA INFRASTRUCTURA DE LA PRODUCCIÓN DOMESTICA
4.6.7.3 INSTITUCIONES DE GOBIERNO Y PARTE PUBLIC-PRIVATE
4.6.7.4 LONG-TERM PROCUREMENT CONTRACTS with HEALTHCARE SYSTEMS
4.6.8 Protección de datos
4.6.8.1 MARCOS DE PROTECCIÓN DE DATOS PARA LOS DATOS CLINICOS Y REALES
4.6.8.2 PROTECCIÓN DE DATOS TRIALES CLINICOS, DATOS PACIENTES Y DESARROLLO DE DROGAS
4.6.8.3 SECURE CLOUD INFRASTRUCTURE FOR SBS-IF DATA MANAGEMENT
4.6.8.4 INTRODUCCIÓN DE LA TERCERA DETECCIÓN DE LA INVESTIGACIÓN Y LAS REDES DE PHARMA
4.6.8.5 CUMPLIMIENTO DE LAS REGULACIONES DE DATOS PHARMACEUTICAS " GXP
4.6.9 NUEVA BUSINESS AND EMERGING REVENUE OPPORTUNITIES " FUTURE OUTLOOK
4.6.10 Conclusión
4.7 EPIDEMIOLOGY
INTRODUCCIÓN
4.7.2 INCIDENCE OF TYPE 1 SBS-IF BY GENDER
4.7.3 TREATMENT RATE
4.7.4 MORTALITY RATE
4.7.5 TREATMENT ADHERENCE AND SWITCH MODEL
4.7.6 TREATMENTO DE TRATAMIENTO
4.7.7 Conclusión
4.8 DISTRIBUCIÓN DE PRODUCTOS Y PROYECTOS POR PEQUEÑO GLOBAL
4.9 DISTRIBUCIÓN DE PROYECTOS POR APROBADO CIENTÍFICO Y FASE – GLOBAL TYPE 1 SBS-IF MARKET
4.1 DISTRIBUCIÓN DE LOS PROYECTOS POR EL AREA Y LA FASE THERAPEUTIC TYPE 1 SBS-IF MARKET
4.11 ANÁLISIS PIPELINA
INTRODUCCIÓN
4.11.2 TRIALS CLINICAL AND PHASE ANALYSIS
4.11.3 PIPELINA DE DROGAS
4.11.4 PHASE III CANDIDATES (E.G., APRAGLUTIDE)
4.11.5 PHASE II CANDIDATES (E.G., LONG-ACTING GLP-2)
4.11.6 FASE I CANDIDATES (EMERGING REGENERATIVE/CELLULAR)
4.11.7 OTHERS (PRE-CLINICAL, EN FORMULATION PIPELINE)
4.11.8 CONCLUSIÓN
4.12 ANÁLISIS PIPELINA
INTRODUCCIÓN
4.12.2 EMPRESA DE LA PHARMACEUTICA DE TAKEDA – LÍADERSHIP DE LA REGENERACIÓN INTESTINAL
4.12.3 BAXTER INTERNATIONAL – PARENTERAL NUTRITION AND INFUSION SYSTEM INNOVATION
4.12.4 FRESENIUS KABI AG – LA NUTRICIÓN CLINICA Y EL DESARROLLO DE LA THERAPY INJECTABLE
4.12.5 NESTLÉ HEALTH SCIENCE – MEDICAL NUTRITION AND GUT ADAPTATION RESEARCH
4.12.6 LABORATORES ABBOTT – INTEGRATED NUTRITION AND METABOLIC MONITORING SOLUTIONS
4.12.7
4.13 ANÁLISIS DE THERAPY MARKETED
INTRODUCCIÓN
4.13.2 DRUG/THERAPY
4.13.2.1 MARCO
4.13.2.2 Nombre de los GENERICES
4.13.3 CLASIFICACIÓN PHARMACOLOGICA
4.13.4 INDICACIÓN PRIMARIA
4.13.5 MARKET STATUS
4.13.6 Medios de acción
4.13.7
4.13.8 DISPONIBILIDAD
4.13.9 PACKAGING TYPE
4.13.10 ROUTE OF ADMINISTRATION
4.13.11 FRECUENCIA DE DOS
4.13.12 INSIGHT
4.13 Una visión general de las actividades de desarrollo de la sequía, las miles de carácter reglamentario, la seguridad y la administración, los datos sobre la exclusividad del mercado
4.13.14 FORECAST MARKET OUTLOOK
4.13.14.1 CROSS COMPETITION
4.13.14.2 THERAPEUTIC PORTFOLIO
4.13.14.3 CURRENT DEVELOPMENT SCENARIO
4.13.15
4.14 ANALISIS PIPELINA - GLOBAL TYPE 1 SBS-IF TREATMENT MARKET
4.14.1 TRIALS CLINICAL AND PHASE ANALYSIS
4.14.2 PIPELINA DE DROGAS Y BIOTHERAPY
4.14.3 PHASE III CANDIDATES
4.14.4 PHASE II CANDIDATES
4.14.5 PHASE I CANDIDATES
4.14.6 OTHERS (PRE-CLINICAL AND RESEARCH STAGE)
4.15 R ' D ANALYSIS
ANÁLISIS COMPARATIVO
4.15.2 LANDSCAPE PARA EL DESARROLLO
4.15.3 INSIGHTS ON REGULATORY MILESTONES
4.15.4 Asistencia técnica
4.15.5 COLABORACIONES Y PARTICIPACIONES DE ASISTENCIA
5 HEALTHCARE TARIFFS IMPACT ANALYSIS
5.1 Examen general
5.2 ESTRUCTURAS DE TARIFF
5.2.1 GLOBAL VS. REGIONAL TARIFF STRUCTURES
5.2.2 ESTADOS UNIDOS: MEDICARE/MEDICAID TARIFF POLICIES
5.2.3 ASIA-PACIFIC: GOVERNMENT TARIFFS ON IMPORTED PN/DRUG THERAPIES
5.2.4 MARKETS EMERGING: TARIFF CHALLENGES FOR NUTRITION " BIOLOGICS
5.2.5 MAJOR MARKET UPTAKE
5.3 TARIFAS PHARMACEUTICAS Y BARRIERS TRADE
5.3.1 IMPORT DUTIES ON PN KITS, GLP-2 VS. GENERICS
5.3.2 IMPACT ON AFFORDABILITY " ACCESS
5.3.3 ACUERDOS DE COMERCIO DE KEY AFECTANDO PRODUCTOS SBS-IF
5.4 IMPACT OF HEALTHCARE TARIFFS ON PROVIDERS/PATIENTS
5.4.1 COST BURDEN ON HOSPITALS AND FACILITIES
5.4.2 EFECTO SOBRE LA AFFORDABILIDAD PACIENTE
5.4.3 HABITACIÓN EN EL TOURISMO MEDICAL PARA LAS ARMAS DE SBS-IF
5.5 ACUERDOS DE COMERCIO Y ACTIVIDADES DE SALUD
5.5.1 REGULACIONES DE LA OMC
5.5.2 EJECUCIÓN DE AGUAS COMERCIALES EN EL CAPÍTULO
5.5.3 FTAS IN REDUCING TARIFFS
5.6 IMPACT OF TARIFFS ON HEALTHCARE COSTS AND ACCESSIBILITY
5.7 IMPORTANCE OF TARIFFS IN THE HEALTHCARE SECTOR
6 MARKET ACCESS
6.1 10 años de duración
6.2 Subsidios regionales
6.3 APROBACIONES NUEVAS DEL FDA ANUAL PARA LOS TRATAMIENTOS SBS-IF
6.4 MANUFACTURES, DISTRIBUTORS, AND DEALS
6.5 MAJOR MARKET UPTAKE
6.6 PRÁCTICAS DE TRATAMIENTO ACTUAL
6.7 IMPACT OF UPCOMING THERAPIES
7 MARCO REGULATORIO –
7.1 INTRODUCCIÓN
7.2 PROCESO DE APROBACIÓN REGULATORIA
7.3 EASE of REGULATORY APPROVAL
7.4 PATHWAYS DE APROBACIÓN REGULATORIA
7.5 LICENCIA Y REGISTRACIÓN
7.6 POST-MARKEILLANCE
7.7 Guías de buenas prácticas de manipulación
7.8 CONCLUSIÓN
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 RISING SBS-IF PATIENT POPULATION
8.1.2 APROBACIÓN DE LA APROBACIÓN DE LAS ARMAS GLP-2
8.1.3 INCREASING GOVERNMENT " ORPHAN DRUG SUPPORT
8.2 RESTRAINTS
8.2.1 GASTOS DE SBS-IF
8.2.2 LIMITE.D AWARENESS & DELAYED DIAGNOSIS
8.3 OPORTUNIDADES
8.3.1 GESTIÓN DE LOS PACIENTES MULTIDISCIPLINARIOS
8.3.2 PROCESOS DE APROBACIÓN REGULATORIA ESTUDIANTE
8.4
8.4.1 AVANCES IN REGENERATIVE MEDICINE
8.4.2 EXPANSION OF HOME-BASED NUTRITIONAL CARE
9 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY
9.1 Examen general
9.2 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
9.2.1 NUTRITIONAL SUPPORT THERAPY
9.2.2 Terapia PHARMACOLOGICA
9.2.3 TREATMENTO SURGICO e INTERVENTIONAL
9.2.4 EMERGING " ADVANCED THERAPIES
9.3 GLOBAL NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.3.1 PARENTERAL NUTRITION (PN)
9.3.2 ENTERAL NUTRITION (EN)
9.3.3 PN COMPOSITION
9.4 NUTRICIÓN PARENTERAL GLOBAL (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
9.4.1 HOME PARENTERAL NUTRITION (HPN)
9.4.2 LA NUTRICIÓN PARENTERAL PERIPHERAL (PPN)
9.4.3 ADPIC PARENTERAL
9.5 LA NUTRICIÓN DE PARENTERAL TOTAL GLOBAL (TPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.5.1 TPN HOSPITAL-BASED
9.5.2 PT PNB
9.6 GLOBAL HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
9.6.1 HPN ADULT
9.6.2 PEDIATRIC HPN
9.7 GLOBAL HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
9.7.1 HPN LONG-TERM
9.7.2 HPN SHORT-TERM
9.8 LA NUTRICIÓN ENTERAL GLOBAL (EN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.8.1 FEEDING ORAL
9.8.2 TUBE FEEDING
9.8.3 FORMULA TYPE
9.9 GLOBAL TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.9.1 NASOGASTRIC (NG)
9.9.2 PEG FEEDING
9.9.3 JEJUNOSTOMY FEEDING
9.1 GLOBAL FORMULA TYPE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.10.1 POLYMERIC
9.10.2 ELEMENTAL
9.10.3 SEMI-ELEMENTAL
9.11 GLOBAL PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.11.1 MACRONUTRIENTS
9.11.2 ELECTROLYTES " FLUIDS
9.11.3 MICRONUTRIENTS
9.12 MACRONUTRIENTES GLOBALES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.12.1 AMINO ACIDS
9.12.2 EMULSIONES LIPID
9.12.3 DEXTROSE
9.13 MICRONUTRIENTS GLOBAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.13.1 VITAMINS
9.13.2 ELEMENTOS DE TRABAJO
9.14 GLOBAL NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
9.14.1 NORTH AMERICA
9.14.2 EUROPA
9.14.3 ASIA-PACIFIC
9.14.4 ORIENTE MEDIO Y ÁFRICA
9.14.5 SOUTH AMERICA
9.15 THERAPY GLOBAL PHARMACOLOGICAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.15.1 Terapia de ADAPTACIÓN HORMONAL
9.15.2 Terapia ANTI-DIARHEAL
9.15.3 ANTI-SECRETORY THERAPY
9.15.4 APLICACIÓN MICRONUTRIENTE
9.15.5 THERAPY ANTI-INFECTIVE
9.15.6 BILE ACID " ABSORPTION MODIFIERS
9.16 THERAPY HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.16.1 ANÁLOGO GLP-2
9.16.2 GROWTH HORMONE THERAPY
9.16.3 IGF-1 " ANALOGUES
9.17 GLOBAL GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.17.1
9.17.2 APRAGLUTIDE (LATE-STAGE)
9.17.3 ANALOGOS GLP-2 DE CUMPLIMIENTO
9.18 GLOBAL GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
9.18.1 HUMATROPE
9.18.2 NORDITROPIN
9.18.3 GENOTROPIN
9.19 GLOBAL IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.19.1 INCRELEX
9.19.2 OTROS
9.2 GLOBAL ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.20.1 OPIOID-BASED
9.20.2 ORGANIZACIONES NO ORGANIZADAS
9.21 GLOBAL OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.21.1 LOPERAMIDE
9.21.2 CODEINA
9.22 THERAPY GLOBAL ANTI-SECRETORY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.22.1 INHIBITORES DE PUMP PROTON
9.22.2 ANÁLOGOS SOMATOSTATALES
9.22.3 H2 RECEPTOR ANTAGONISTAS
9.23 GLOBAL PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.23.1 OMEPRAZOLE
9.23.2 PANTOPRAZOLE
9.23.3 ESOMEPRAZOLE
9.23.4 OTROS
9.24 ANÁLOGO GLOBAL SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE , 2018-2033 (US$ THOUSAND)
9.24.1 OCTREOTIDE
9.24.2 OTROS
9.25 GLOBAL H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.25.1 FAMOTIDINE
9.25.2 OTROS
9.26 SUPLEMENTACIÓN MICRONUTRIENTE GLOBAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.26.1 VITAMINAS FAT-SOLUBLE (A, D, E, K)
9.26.2 ELECTROLYTES
9.26.3 VITAMIN B12
9.26.4 APLICACIÓN MINERAL
9.27 THERAPY ANTI-INFECTIVE GLOBAL EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.27.1 ANTÍTICOS BROAD-SPECTRUM
9.27.2 THERAPY
9.28 GLOBAL BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.28.1 BILE ACID SEQUESTRANTS
9.28.2 FAT ABSORPTION ENHANCERS
9.29 SEQUESTRANTES GLOBAL BILE ACID EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.29.1
9.29.2 COLESEVELAM
9.29.3 Otros
9.3 THERAPY GLOBAL PHARMACOLOGICAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
9.30.1 NORTH AMERICA
9.30.2 EUROPA
9.30.3 ASIA-PACIFIC
9.30.4 ORIENTE MEDIO Y ÁFRICA
9.30.5 SOUTH AMERICA
9.31 TREATMENTO SURGICO GLOBAL " INTERVENTIONAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.31.1 PROCEDIMIENTOS DE LA LENGTHENAL
9.31.2 OSTOMÍA " RECONSTRUCCIÓN "
9.31.3 TRANSPLANTACIÓN INTESTINAL
9.32 GLOBAL INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.32.1
9.32.2 BIANCHI PROCEDURE
9.33 GLOBAL OSTOMY " RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.33.1
9.33.2 JEJUNOSTOMY
9.33.3 REVERSAL SURGERY
9.34 TRANSPLANTACIÓN GLOBAL INTESTINAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.34.1 CENTRO SMALL ISOLATED
9.34.2 LIVER + INTESTINE
9.34.3 TRANSPLANT MULTIVISCERAL
9.35 TREATMENTO SURGICO GLOBAL " INTERVENTIONAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL)
9.35.1 NORTH AMERICA
9.35.2 EUROPA
9.35.3 ASIA-PACIFIC
9.35.4 ORIENTE MEDIO Y ÁFRICA
9.35.5 SOUTH AMERICA
9.36 GLOBAL EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.36.1 MEDICINA
9.36.2 Terapia de apoyo a la MICROBIOME
9.36.3 GENE THERAPY
9.37 GLOBAL REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.37.1
9.37.2 INTESTINA TISSUE-ENGINEERED
9.38 GLOBAL MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.38.1
9.38.2 FMT
9.39 GLOBAL GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.39.1 Inicio de la FUNCIÓN ABSORPTIVE
9.39.2 MUCOSAL GROWTH MODULATION
9.4 GLOBAL EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
9.40.1 NORTH AMERICA
9.40.2 EUROPA
9.40.3 ASIA-PACIFIC
9.40,4 MIDDLE EAST AND AFRICA
9.40.5 SOUTH AMERICA
10 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION
10.1 Examen general
10.2 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
10.2.1 CORE SBS-IF MARKET
10.2.2 SBS-IF
10.2.3 ADJACENT / NON-SPECIFIC MARKET
10.3 GLOBAL CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
10.3.1 PARENTERAL NUTRITION
10.3.2 ANÁLOGO GLP-2
10.4 MERCADO GLOBAL CORE SBS-IF en TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (US$ THOUSAND)
10.4.1 NORTH AMERICA
10.4.2 EUROPA
10.4.3 ASIA-PACIFIC
10.4.4 EAST MIDDLE Y AFRICA
10.4.5 SOUTH AMERICA
10,5 GLOBAL SBS-IF ATTRIBUTABLE MARKET EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
10.5.1 ANTI-DIARRHEALS
10.5.2 PPIS
10.5.3 ANTÍTICOS
10.6 GLOBAL SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (US$ THOUSAND)
10.6.1 NORTH AMERICA
10.6.2 EUROPA
10.6.3 ASIA-PACIFIC
10.6.4 Medio Oriente y ÁFRICA
10.6.5 SOUTH AMERICA
10.7 GLOBAL ADJACENT / NON-SPECIFIC MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
10.7.1 NORTH AMERICA
10.7.2 EUROPA
10.7.3 ASIA-PACIFIC
10.7.4 Aire acondicionado y ÁFRICA
10.7.5 SOUTH AMERICA
11 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE
11.1 Examen general
11.2 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
11.2.1 ACUTE PHASE (TYPE 1 SBS-IF)
11.2.2 FASE DE ADAPTACIÓN
11.2.3 FASE RECOVERY
11.3 ACUTE GLOBAL PHASE (TYPE 1 SBS-IF) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
11.3.1 NORTH AMERICA
11.3.2 EUROPA
11.3.3 ASIA-PACIFIC
11.3.4 Medio Oriente y ÁFRICA
11.3.5 SOUTH AMERICA
11.4 ADAPTACIÓN GLOBAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
11.4.1 NORTH AMERICA
11.4.2 EUROPA
11.4.3 ASIA-PACIFIC
11.4.4. EAST MIDDLE Y AFRICA
11.4.5 SOUTH AMERICA
11.5 FASE GLOBAL RECOVERY PHASE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
11.5.1 NORTH AMERICA
11.5.2 EUROPA
11.5.3 ASIA-PACIFIC
11.5.4 Medio Oriente y ÁFRICA
11.5.5 SOUTH AMERICA
12 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE
12.1 Examen general
12.2 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
12.2.1 ADULT
12.2.2 PEDIATRIC
12.3 GLOBAL ADULT IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
12.3.1 NORTE AMERICA
12.3.2 EUROPA
12.3.3 ASIA-PACIFIC
12.3.4 Aire acondicionado
12.3.5 SOUTH AMERICA
12.4 GLOBAL PEDIATRIC IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
12.4.1 NORTH AMERICA
12.4.2 EUROPA
12.4.3 ASIA-PACIFIC
12.4.4. EAST MIDDLE Y AFRICA
12.4.5 SOUTH AMERICA
13 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION
13.1 Examen general
13.2 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
13.2.1 INTRAVENCION
13.2.2
13.2.3 ORAL
13.2.4 ENTERAL
13.3 INTRAVENIO GLOBAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
13.3.1 PN
13.3.2
13.4 GLOBAL INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
13.4.1 NORTE AMERICA
13.4.2 EUROPA
13.4.3 ASIA-PACIFIC
13.4.4 Aire acondicionado y ÁFRICA
13.4.5 SOUTH AMERICA
13.5 GLOBAL SUBCUTANEOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
13.5.1 NORTE AMERICA
13.5.2 EUROPA
13.5.3 ASIA-PACIFIC
13.5.4 Medio Oriente y ÁFRICA
13.5.5 SOUTH AMERICA
13.6 GLOBAL ORAL IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
13.6.1 NORTE AMERICA
13.6.2 EUROPA
13.6.3 ASIA-PACIFIC
13.6.4 Medio Oriente y ÁFRICA
13.6.5 SOUTH AMERICA
13.7 ENTERAL GLOBAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
13.7.1 NORTH AMERICA
13.7.2 EUROPA
13.7.3 ASIA-PACIFIC
13.7.4 Medio Oriente y ÁFRICA
13.7.5 SOUTH AMERICA
14 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER
14.1 Examen general
14.2 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
14.2.1 HOSPITALS (ACUTE CARE)
14.2.2 Home CARE (Programas de HPN)
14.2.3 SETTINGS ICU
14.2.4 CENTROS PECIALTY GI
14.2.5 PEDIATRIC SPECIALTY HOSPITALS
14.3 HOSPITALS GLOBAL (ACUTE CARE) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY REGION, 2018-2033, (US$ THOUSAND)
14.3.1 NORTE AMERICA
14.3.2 EUROPA
14.3.3 ASIA-PACIFIC
14.3.4 Medio Oriente y ÁFRICA
14.3.5 SOUTH AMERICA
14.4 GLOBAL HOME CARE (HPN PROGRAMS) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
14.4.1 NORTH AMERICA
14.4.2 EUROPA
14.4.3 ASIA-PACIFIC
14.4.4 ORIENTE MEDIO Y ÁFRICA
14.4.5 SOUTH AMERICA
14.5 SETTINGS GLOBAL ICU en TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
14.5.1 NORTE AMERICA
14.5.2 EUROPA
14.5.3 ASIA-PACIFIC
14.5.4 Medio Oriente y ÁFRICA
14.5.5 SOUTH AMERICA
14.6 GLOBAL SPECIALTY GI CENTROS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
14.6.1 NORTE AMERICA
14.6.2 EUROPA
14.6.3 ASIA-PACIFIC
14.6.4 Medio Oriente y ÁFRICA
14.6.5 SOUTH AMERICA
14.7 HOSPITALS GLOBAL PEDIATRIC SPECIALTY HOSPITALS IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
14.7.1 NORTH AMERICA
14.7.2 EUROPA
14.7.3 ASIA-PACIFIC
14.7.4 Medio Oriente y ÁFRICA
14.7.5 SOUTH AMERICA
15 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL
15.1 Examen general
15.2 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
15.2.1 HOSPITAL PHARMACY
15.2.2 PHARMACY ESPECIAL
15.2.3 RETAIL PHARMACY
15.2.4 PHARMACY ONLINE
15.3 PHARMACIDAD HOSPITAL GLOBAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
15.3.1 NORTE AMERICA
15.3.2 EUROPA
15.3.3 ASIA-PACIFIC
15.3.4 ORIENTE MEDIO Y ÁFRICA
15.3.5 SOUTH AMERICA
15.4 GLOBAL SPECIALTY PHARMACY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
15.4.1 NORTH AMERICA
15.4.2 EUROPA
15.4.3 ASIA-PACIFIC
15.4.4 ORIENTE MEDIO Y ÁFRICA
15.4.5 SOUTH AMERICA
15.5 GLOBAL RETAIL PHARMACY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
15.5.1 NORTE AMERICA
15.5.2 EUROPA
15.5.3 ASIA-PACIFIC
15.5.4 ORIENTE MEDIO Y ÁFRICA
15.5.5 SOUTH AMERICA
16 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION
16.1 Examen general
16.2 NORTH AMERICA
16.2.1 Estados Unidos
16.2.2 CANADA
16.2.3 MEXICO
16.3 EUROPA
16.3.1 ALEMANIA
16.3.2
16.3.3 FRANCIA
16.3.4
16.3.5 ESPAÑA
16.3.6 TURKEY
16.3.7 RUSSIA
16.3.8 NETHERLANDS
16.3.9 SUIZA
16.3.10 BELGIUM
16.3.11 SWEDEN
16.3.12 DENMARK
16.3.13 NORUEGA
16.3.14 FINLANDIA
16.3.15 Prueba de EUROPA
16.4 ASIA PACIFIC
16.4.1 JAPÓN
16.4.2 CHINA
16.4.3 SOUTH KOREA
16.4.4 INDIA
16.4.5 SINGAPORE
16.4.6 THAILAND
16.4.7 INDONESIA
16.4.8 MALAYSIA
16.4.9 PHILIPPINES
16.4.10 BELGIUM
16.4.11 NUEVA ZELANDA
16.4.12 HONG KONG
16.4.13 TAIWAN
16.4.14 REST OF ASIA-PACIFIC
16,5 SOUTH AMERICA
16.5.1 BRASIL
16.5.2 ARGENTINA
16.5.3 COLOMBIA
16.5.4 CHILE
16.5.5 PERU
16.5.6 ECUADOR
16.5.7 URUGUAY
16.5.8 VENEZUELA .
16.5.9 BOLIVIA
16.5.10 PARAGUAY
16.5.11 Prueba del Sur de América
16,6 MIDDLE EAST AND AFRICA
16.6.1 ARABIA SAUDIO
16.6.2 ÁFRICA SUR
16.6.3 EGIPTO
16.6.4 ISERAEL
16.6.5 EMIRATES DE LAS NACIONES UNIDAS
16.6.6 KUWAIT
16.6.7 OMAN
16.6.8 QATAR
16.6.9 BAHRAIN
16.6.10 REST OF MIDDLE EAST AND AFRICA
17 GLOBAL GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: COMPANY LANDSCAPE
17.1 MANUFACTURER COMPANY SHARE ANALYSIS: GLOBAL
17.2 MANUFACTURER COMPANY SHARE ANALYSIS: ASIA-PACIFIC
17.3 MANUFACTURER COMPANY SHARE ANALYSIS: EUROPE
17.4 MANUFACTURER COMPANY SHARE ANALYSIS: NORTH AMERICA
18 ANALISIS SWOT
19 PROFILES DE EMPRESA
19.1 FRESENIUS KABI
19.1.1 SNAPSHOT
19.1.2 ANÁLISIS REVENIDO
19.1.3 COMPANY SHARE ANALISIS
19.1.4 PRODUCTO PORTFOLIO
19.1.5 DESARROLLO RECIENTE
19.2 BAXTER INTERNATIONAL INC.
19.2.1 SNAPSHOT COMPANY
19.2.2 ANÁLISIS REVENIDO
19.2.3 COMPANY SHARE ANALISIS
19.2.4 PRODUCTO PORTFOLIO
19.2.5 DESARROLLO RECIENTE
19.3 NESTLÉ HEALTH SCIENCE
19.3.1
19.3.2 ANÁLISIS REVENIDO
19.3.3 COMPANY SHARE ANALISIS
19.3.4 PRODUCTO PORTFOLIO
19.3.5 DESARROLLO RECIENTE
19.4 LABORATORIAS ABBOTT
19.4.1
19.4.2 ANÁLISIS REVENIDO
19.4.3 COMPANY SHARE ANALISIS
19.4.4 PRODUCTO PORTFOLIO
19.4.5 DESARROLLO RECIENTE
19.5 TAKEDA PHARMACEUTICAL COMPANY LIMITADA
19.5.1 SNAPSHOT
19.5.2 ANÁLISIS REVENIDO
19.5.3 ANÁLISIS DE COMPANÍA
19.5.4 PRODUCTO PORTFOLIO
19.5.5 DESARROLLO RECIENTE
19.6 MOOG COMPANY
19.6.1 SNAPSHOT
19.6.2 ANÁLISIS REVENIDO
19.6.3 PRODUCTO PORTFOLIO
19.6.4 RECENT DEVELOPMENT/NEWS
19.7 ACULIFE HEALTHCARE
19.7.1
19.7.2 PRODUCTO PORTFOLIO
19.7.3 DESARROLLO RECIENTE
19.8 AMSINO INTERNATIONAL, INC
19.8.1 SNAPSHOT
19.8.2 PRODUCTO PORTFOLIO
19.8.3 DESARROLLO RECIENTE
19.9 AURORA
19.9.1
19.9.2 PRODUCTO PORTFOLIO
19.9.3 DESARROLLO RECIENTE
19.1 AMERIPHARMA Cuidado especial.
19.10.1 SNAPSHOT
19.10.2 PRODUCTO PORTFOLIO
19.10.3 DESARROLLO RECIENTE
19.11 Principales empresas de salud
19.11.1
19.11.2 ANÁLISIS REVENIDO
19.11.3 PRODUCTO PORTFOLIO
19.11.4 DESARROLLO RECIENTE
19.12 VELIGROSAS DIGESTIVE CARE
19.12.1
19.12.2 PRODUCTO PORTFOLIO
19.12.3 DESARROLLO RECIENTE
19.13 B. BRAUN SE
19.13.1
19.13.2 PRODUCTO PORTFOLIO
19.13.3 DESARROLLO RECIENTE
19.14 CAMVITTA
19.14.1
19.14.2 PRODUCTO PORTFOLIO
19.14.3 DESARROLLO RECIENTE
19.15 CHOICE PARENTERAL NUTRITION LLC
19.15.1
19.15.2 PRODUCTO PORTFOLIO
19.15.3 DESARROLLO RECIENTE
19.16 CONTINUUMRX
19.16.1
19.16.2 PRODUCTO PORTFOLIO
19.16.3 DESARROLLO RECIENTE
19.17 PHARMACEUTICAS
19.17.1
19.17.2 PRODUCTO PORTFOLIO
19.17.3 DESARROLLO RECIENTE
19.18 GRIFOLS S.A.
19.18.1
19.18.2 ANÁLISIS REVENIDO
19.18.3 PRODUCTO PORTFOLIO
19.18.4 DESARROLLO RECIENTE
19.19 PHARMACEUTICAS HIKMA
19.19.1
19.19.2 ANÁLISIS REVENIDO
19.19.3 PRODUCTO PORTFOLIO
19.19.4 DESARROLLO RECIENTE
19.2 HOSPIRA (PART OF PFIZER INC.)
19.20.1
19.20.2 ANÁLISIS REVENIDO
19.20.3 PRODUCTO PORTFOLIO
19.20.4 DESARROLLO RECIENTE
19.21 HANMI PHARM.CO.,LTD.
19.21.1
19.21.2 ANÁLISIS REVENIDO
19.21.3 PRODUCTO PORTFOLIO
19.21.4 DESARROLLO RECIENTE
19.22 MEDICAL DE UCI, INC.
19.22.1
19.22.2 ANÁLISIS REVENIDO
19.22.3 PRODUCTO PORTFOLIO
19.22.4 DESARROLLO RECIENTE
19.23 SOLUCIONES DE INFUSIÓN
19.23.1
19.23.2 PRODUCTO PORTFOLIO
19.23.3 DESARROLLO RECIENTE
19.24 SISTEMAS DE CARE INTEGRAADOS
19.24.1 SNAPSHOT
19.24.2 PRODUCTO PORTFOLIO
19.24.3 DESARROLLO RECIENTE
19.25 JEDUX PARENTERAL PRIVATE LIMITADA
19.25.1
19.25.2 PRODUCTO PORTFOLIO
19.25.3 DESARROLLO RECIENTE
19.26 LABORATOIRE DIELEN
19.26.1 SNAPSHOT COMPANY
19.26.2 PRODUCTO PORTFOLIO
19.26.3 DESARROLLO RECIENTE
19.27 NAPO THERAPEUTICS.
19.27.1
19.27.2 PRODUCTO PORTFOLIO
19.27.3 RECENT DEVELOPMENT/NEWS
19.28 NUTREGO
19.28.1 SNAPSHOT
19.28.2 PRODUCTO PORTFOLIO
19.28.3 DESARROLLO RECIENTE
19.29 NUTRICIA (Grupo de Dinamarca)
19.29.1 SNAPSHOT
19.29.2 ANÁLISIS REVENIDO
19.29.3 PRODUCTO PORTFOLIO
19.29.4 DESARROLLO RECIENTE
19.3 NUTRICIA NORTH AMERICA
19.30.1
19.30.2 PRODUCTO PORTFOLIO
19.30.3 DESARROLLO RECIENTE
19.31 NUTRISHARE
19.31.1
19.31.2 PRODUCTO PORTFOLIO
19.31.3 DESARROLLO RECIENTE
19.32 OXTHERA
19.32.1
19.32.2 PRODUCTO PORTFOLIO
19.32.3 DESARROLLO RECIENTE
19.33 PHARMKO, INC.
19.33.1
19.33.2 PRODUCTO PORTFOLIO
19.33.3 DESARROLLO RECIENTE
19.34 PUERTO LIFE SCIENCES PVT. LTD.
19.34.1 COMPANY SNAPSHOT
19.34.2 PRODUCTO PORTFOLIO
19.34.3 DESARROLLO RECIENTE
19.35 SHANDONG QIDU PHARMACEUTICAL CO., LTD.
19.35.1 SNAPSHOT COMPANY
19.35.2 PRODUCTO PORTFOLIO
19.35.3 DESARROLLO RECIENTE
19.36 Cuidado de la salud permanente
19.36.1
19.36.2 PRODUCTO PORTFOLIO
19.36.3 DESARROLLO RECIENTE
19.37 UF HEALTH
19.37.1
19.37.2 PRODUCTO PORTFOLIO
19.37.3 DESARROLLO RECIENTE
19.38 PHARMACEUTICAS IRONWOOD
19.38.1
19.38.2 ANÁLISIS REVENIDO
19.38.3 PRODUCTO PORTFOLIO
19.38.4 DESARROLLO RECIENTE
19.39 VISION PARENTERAL
19.39.1 COMPANY SNAPSHOT
19.39.2 PRODUCTO PORTFOLIO
19.39.3 DESARROLLO RECIENTE
19.4 ZEALAND PHARMA
19.40.1
19.40.2 ANÁLISIS REVENIDO
19.40.3 PRODUCTO PORTFOLIO
19.40.4 DESARROLLO RECIENTE
20 CUESTIÓN
21 INFORMES CONEXOS
Lista de Tablas
CUADRO 1 TREATMENTO DE LOS PACIENTES DEL OSE-IF
CUADRO 2 POBLACIONES PACIENTES ESTIMADAS
Cuadro 3
TABLE 4 KEY INDUSTRY INSIGHTS AND MARKET TRENDS IN THE GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET
TABLE 5 IMPACT OF WAR-DRIVEN DISRUPTIONS ON THE GLOBAL TYPE 1 SBS-IF TREATMENT MARKET ECOSYSTEM AND INDUSTRY RESPONSE FRAMEWORK
CUADRO 6 DISTRIBUCIÓN DE PRODUCTOS Y PROYECTOS POR PHASE GLOBAL TYPE 1 SBS-IF MARKET
CUADRO 7 DISTRIBUCIÓN DE LOS PROYECTOS POR APROBADO CIENTÍFICO Y FASE – GLOBAL TYPE 1 SBS-IF MARKET
CUADRO 8 DISTRIBUCIÓN DE PROYECTOS POR EL AREA Y LA FASE THERAPEUTIC TYPE 1 SBS-IF MARKET
CUADRO 9 PIPELINE LANDSCAPE Y DESARROLLO CLINICO
CUADRO 10 TÉCNICAS BASADAS EN GLANCE R Pulido – GLOBAL TYPE 1 SBS-IF TREATMENT MARKET
CUADRO 11 CANDIDATOS PRECLINICOS/RESEARCH
TABLE 12 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 13 GLOBAL NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 14 DE PARENTERAL GLOBAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 15 GLOBAL TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 16 GLOBAL HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 17 GLOBAL HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 18 NUTRICIÓN ENTERAL GLOBAL (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 19 GLOBAL TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 20 GLOBAL FORMULA TYPE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 21 GLOBAL PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 22 MACRONUTRIENTES GLOBALES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 23 MICRONUTRIENTS GLOBAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 24 GLOBAL NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 25 GLOBAL PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 26 GLOBAL HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 27 ANALOGÍAS GLOBAL GLP-2 EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 28 GLOBAL GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 29 GLOBAL IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 30 GLOBAL ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 31 GLOBAL OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 32 GLOBAL ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 33 GLOBAL PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 34 ANÁLOGO DE SOMATOSTATINA GLOBAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE , 2018-2033 (US$ THOUSAND)
CUADRO 35 GLOBAL H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 36 SUPLEMENTO DE MICRONUTRIENTE GLOBAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 37 GLOBAL ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED THOUSAND)
TABLE 38 GLOBAL BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 39 SEQUESTRANTES GLOBAL BILE ACID EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 40 GLOBAL PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 41 GLOBAL SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 42 PROCEDIMIENTOS DE LENGTHENING GLOBAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 43 GLOBAL OSTOMY " RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 44 GLOBAL INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 45 GLOBAL SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 46 GLOBAL EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 47 GLOBAL REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 48 GLOBAL MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 49 GLOBAL GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 50 GLOBAL EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 51 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 52 GLOBAL CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 53 GLOBAL CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
CUADRO 54 GLOBAL SBS-IF EN TYPE 1 SBS-IF (SYNDROME BOWEL SYNDROME con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 55 GLOBAL SBS-IF EN TYPE 1 SBS-IF (SYNDROME BOWEL SYNDROME con FAILURE INTESTINAL) TREATMENT MARKET, POR REGION, 2018-2033, (US$ THOUSAND)
CUADRO 56 GLOBAL / MARKET NO ESPECÍFICO EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR REGION, 2018-2033, (US$ THOUSAND)
TABLE 57 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 58 GLOBAL ACUTE PHASE (TYPE 1 SBS-IF) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
CUADRO 59 DE ADAPTACIÓN GLOBAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 60 GLOBAL RECOVERY PHASE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 61 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 62 GLOBAL ADULT IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 63 GLOBAL PEDIATRIC EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 64 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 65 GLOBAL INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 66 GLOBAL INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 67 GLOBAL SUBCUTANEOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 68 GLOBAL ORAL IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
CUADRO 69 GLOBAL ENTERAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 70 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 71 HOSPITALS GLOBAL (ACUTE CARE) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR REGION, 2018-2033, (US$ THOUSAND)
TABLE 72 GLOBAL HOME CARE (Programas HPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, BY REGION, 2018-2033, (US$ THOUSAND)
CUADRO 73 SETTINGS GLOBAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 74 GLOBAL SPECIALTY GI CENTROS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
CUADRO 75 HOSPITALSAS GLOBAL PEDIATRIC ESPECIAL EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (US$ THOUSAND)
TABLE 76 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 77 GLOBAL HOSPITAL PHARMACY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 78 GLOBAL SPECIALTY PHARMACY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 79 GLOBAL RETAIL PHARMACY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 80 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 81 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 82 GLOBAL NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 83 PARENTERAL GLOBAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 84 GLOBAL TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 85 GLOBAL HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 86 GLOBAL HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 87 NUTRICIÓN ENTERAL GLOBAL (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 88 GLOBAL TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 89 GLOBAL FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 90 GLOBAL PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 91 MACRONUTRIENTES GLOBAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 92 MICRONUTRIENTS GLOBAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 93 GLOBAL NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
CUADRO 94 PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 95 GLOBAL HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 96 GLOBAL GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 97 GLOBAL GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 98 GLOBAL IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 99 GLOBAL ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 100 GLOBAL OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 101 THERAPY GLOBAL ANTI-SECRETORY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 102 GLOBAL PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 103 ANÁLOGO GLOBAL SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (US$ THOUSAND)
TABLE 104 GLOBAL H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 105 GLOBAL MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 106 GLOBAL ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 107 GLOBAL BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 108 SEQUESTRANTES DE CALIDAD GLOBAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 109 GLOBAL PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 110 GLOBAL SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 111 GLOBAL INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 112 GLOBAL OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 113 GLOBAL INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 114 GLOBAL SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 115 GLOBAL EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 116 GLOBAL REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 117 GLOBAL MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 118 GLOBAL GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 119 GLOBAL EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 120 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 121 GLOBAL CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 122 GLOBAL CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
CUADRO 123 GLOBAL SBS-IF EN TYPE 1 SBS-IF (SYNDROME BOWEL SYNDROME con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 124 GLOBAL SBS-IF EN TYPE 1 SBS-IF (SYNDROME BOWEL SYNDROME CON FAILURE INTESTINAL) TREATMENT MARKET, POR REGION, 2018-2033, (US$ THOUSAND)
TABLE 125 GLOBAL ADJACENT / NON-SPECIFIC MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 126 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 127 GLOBAL ACUTE PHASE (TYPE 1 SBS-IF) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
CUADRO 128 ADAPTACIÓN GLOBAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 129 GLOBAL RECOVERY PHASE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 130 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 131 GLOBAL ADULT IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
CUADRO 132 GLOBAL PEDIATRIC EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 133 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 134 GLOBAL INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 135 GLOBAL INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 136 GLOBAL SUBCUTANEOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 137 GLOBAL ORAL IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 138 GLOBAL ENTERAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 139 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 140 HOSPITALS GLOBAL (ACUTE CARE) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR REGION, 2018-2033, (US$ THOUSAND)
CUADRO 141 GLOBAL HOME CARE (Programas HPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY REGION, 2018-2033, (US$ THOUSAND)
TABLE 142 SETTINGS GLOBAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 143 GLOBAL SPECIALTY GI CENTROS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 144 GLOBAL PEDIATRIC SPECIALTY HOSPITALS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 145 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 146 GLOBAL HOSPITAL PHARMACY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 147 GLOBAL SPECIALTY PHARMACY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 148 GLOBAL RETAIL PHARMACY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 149 NORTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, 2018-2033 (USD THOUSAND)
TABLE 150 NORTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 151 NORTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 152 NORTH AMERICA NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 153 NORTH AMERICA PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 154 NORTH AMERICA TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 155 NORTH AMERICA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 156 NORTH AMERICA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 157 NORTH AMERICA ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 158 NORTH AMERICA TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 159 NORTH AMERICA FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 160 NORTH AMERICA PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 161 MACRONUTRIENTES NORTH AMERICA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 162 MICRONUTRIENTES NORTH AMERICA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 163 NORTH AMERICA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 164 NORTH AMERICA HORMONAL ' INTESTINAL ADAPTATION THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 165 NORTH AMERICA GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 166 NORTH AMERICA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 167 NORTH AMERICA IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 168 NORTH AMERICA ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 169 NORTH AMERICA OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 170 NORTH AMERICA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 171 NORTH AMERICA PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 172 NORTH AMERICA SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
TABLE 173 NORTH AMERICA H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 174 NORTH AMERICA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 175 NORTH AMERICA ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 176 NORTH AMERICA BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 177 NORTH AMERICA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 178 NORTH AMERICA SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 179 NORTH AMERICA INTESTINAL LENGTHENING PROCEDURES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 180 NORTH AMERICA OSTOMY " RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 181 TRANSPLANTACIÓN INTESTINAL NORTH AMERICA EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED)
TABLE 182 NORTH AMERICA EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 183 NORTH AMERICA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 184 NORTH AMERICA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 185 NORTH AMERICA GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 186 NORTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 187 NORTH AMERICA CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 188 NORTH AMERICA SBS-IF EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 189 NORTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 190 NORTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 191 NORTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 192 NORTH AMERICA INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 193 NORTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 194 NORTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 195 US TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 196 US NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 197 US PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 198 US TOTAL PARENTERAL NUTRITION (TPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 199 US HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 200 US HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 201 NUTRICIÓN ENTERAL (EN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 202 US TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 203 US FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 204 US PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 205 MACRONUTRIENTES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 206 US MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 207 US PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 208 US HORMONAL < INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 209 US GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 210 US GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
TABLE 211 US IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 212 US ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 213 US OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 214 US ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 215 US PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 216 ANALOGÍAS SOMATOSTATIN EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
TABLE 217 US H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 218 US MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 219 US ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 220 US BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 221 US BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 222 US SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 223 US INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 224 US OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 225 US INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 226 US EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 227 US REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 228 US MICROBIOME-BASED THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 229 US GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 230 US TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 231 US CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 232 US SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 233 US TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 234 US TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 235 US TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 236 US INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 237 US TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 238 US TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 239 CANADA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 240 CANADA NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 241 CANADA PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 242 CANADA TOTAL PARENTERAL NUTRITION (TPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 243 CANADA HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 244 CANADA HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
TABLE 245 CANADA ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 246 CANADA TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 247 CANADA FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 248 CANADA PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 249 MACRONUTRIENTS CANADA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 250 MICRONUTRIENTES CANADAS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 251 PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED THOUSAND)
TABLE 252 CANADA HORMONAL " INTESTINAL ADAPTATION THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 253 CANADA GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 254 CANADA GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 255 CANADA IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 256 CANADA ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 257 CANADA OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 258 CANADA ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 259 INHIBITORES DE PUMP CANADA EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 260 ANÁLOGO SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE , 2018-2033 (US$ THOUSAND)
TABLE 261 CANADA H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 262 CANADA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 263 CANADA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 264 CANADA BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 265 SEQUESTRANTES CANADAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 266 TREATMENTO SURGICO e INTERVENTIONAL CANADA EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 267 PROCEDIMIENTOS DE LENGTHENING CANADA EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 268 CANADA OSTOMY " RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 269 TRANSPLANTACIÓN INTESTINAL CANADA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 270 CANADA EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 271 MEDICINA REGENERATIVO DE CANADA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 272 CANADA MICROBIOME-BASED THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 273 CANADA GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 274 CANADA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 275 CANADA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 276 CANADA SBS-IF ATRIBUTABLE EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 277 CANADA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 278 CANADA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 279 CANADA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 280 CANADA INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 281 CANADA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 282 CANADA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 283 MÉXICO TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 284 MÉXICO NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 285 MÉXICO PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 286 MÉXICO TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 287 MÉXICO HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 288 MÉXICO HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 289 MÉXICO ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 290 MÉXICO TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 291 MÉXICO FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 292 MÉXICO PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 293 MEXICO MACRONUTRIENTS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 294 MEXICO MICRONUTRIENTS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 295 MEXICO PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 296 MÉXICO HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 297 ANALOGOS MÉXICOS GLP-2 EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 298 MEXICO GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USTED)
CUADRO 299 MÉXICO IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 300 MÉXICO ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 301 MÉXICO OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 302 MÉXICO ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 303 MÉXICO PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 304 ANALOGOS SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE , 2018-2033 (US$ THOUSAND)
TABLE 305 MÉXICO H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 306 MEXICO MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 307 MÉXICO ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 308 MÉXICO ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 309 MÉXICO BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 310 MÉXICO SURGICA " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 311 PROCEDIMIENTOS DE LENGTHENING MÉXICO EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 312 MÉXICO OSTOMY " RECONSTRUCCIÓN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 313 MÉXICO TRANSPLANTACIÓN INTESTINAL EN TÍPEA 1 SBS-IF (SHORT BOWEL SYNDROME CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 314 MÉXICO EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 315 MÉXICO MEDICINA REGENERATIVO EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 316 MÉXICO MICROBIOME-BASED THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 317 MÉXICO GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 318 MÉXICO TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 319 MÉXICO CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 320 MÉXICO SBS-IF EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 321 MÉXICO TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 322 MÉXICO TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 323 MÉXICO TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 324 MÉXICO INTRAVENOUS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 325 MÉXICO TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 326 MÉXICO TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 327 EUROPA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, 2018-2033 (USD THOUSAND)
CUADRO 328 EUROPA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
CUADRO 329 EUROPA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
CUADRO 330 EUROPA NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 331 EUROPA PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 332 EUROPA TOTAL PARENTERAL NUTRITION (TPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 333 EUROPA HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 334 EUROPA HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 335 EUROPA ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 336 EUROPA TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 337 EUROPE FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 338 EUROPA PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 339 EUROPA MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 340 EUROPA MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 341 EUROPE PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 342 EUROPA DE ADAPTACIÓN HORMONAL " INTESTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 343 EUROPA GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 344 EUROPE GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 345 EUROPA IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 346 EUROPA ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 347 EUROPA OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 348 EUROPA ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 349 EUROPA PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 350 EUROPA ANÁLOGO SOMATOSTATIN EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 351 EUROPA H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 352 EUROPE MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 353 EUROPA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 354 EUROPE BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 355 EUROPE BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 356 EUROPA TREATMENTO SURGICO " INTERVENTIONAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 357 EUROPA PROCEDIMIENTOS DE LENGTHENING INTESTINAL EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED THOUSAND)
CUADRO 358 EUROPA OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 359 EUROPA TRANSPLANTACIÓN INTESTINAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 360 EUROPE EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 361 EUROPA MEDICINA REGENERATIVO EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 362 EUROPA MICROBIOME-BASED THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 363 EUROPE GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 364 EUROPA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 365 EUROPA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 366 EUROPE SBS-IF ATTRIBUTABLE MARKET EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 367 EUROPA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
CUADRO 368 EUROPA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 369 EUROPA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 370 EUROPA INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 371 EUROPA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 372 EUROPA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 373 USD
TABLE 374 GERMANY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 375 GERMANY NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 376 GERMANY PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 377 GERMANY TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 378 GERMANY HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 379 GERMANY HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 380 GERMANY ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 381 GERMANY TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 382 GERMANY FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 383 GERMANY PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 384 GERMANY MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 385 GERMANY MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 386 GERMANY PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 387 GERMANY HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 388 GERMANY GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 389 GERMANY GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 390 GERMANY IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 391 GERMANY ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 392 GERMANY OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 393 GERMANY ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 394 GERMANY PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 395 GERMANY SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 396 GERMANY H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 397 GERMANY MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 398 GERMANY ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 399 GERMANY BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 400 GERMANY BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 401 GERMANY SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 402 GERMANY INTESTINAL LENGTHENING PROCEDURES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 403 OSTOMÍA DE ALEMANIA " RECONSTRUCCIÓN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 404 GERMANY INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 405 GERMANY EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 406 GERMANY REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 407 GERMANY MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 408 GERMANY GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 409 GERMANY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 410 GERMANY CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 411 GERMANY SBS-IF ATTRIBUTABLE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 412 GERMANY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 413 GERMANY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 414 GERMANY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 415 GERMANY INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 416 GERMANY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 417 GERMANY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 418 USD
CUADRO 419 U.K. TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 420 U.K. NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 421 U.K. PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 422 U.K. TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 423 U.K. HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 424 U.K. HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 425 U.K. ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 426 U.K. TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 427 U.K. FORMULA TYPE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 428 U.K. PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 429 U.K. MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 430 U.K. MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 431 U.K. THERAPY PHARMACOLOGICAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 432 U.K. HORMONAL " INTESTINAL ADAPTATION THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (USTED)
CUADRO 433 U.K. GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 434 U.K. GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USTED)
CUADRO 435 U.K. IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 436 U.K. ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 437 U.K. OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 438 U.K. ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 439 U.K. PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 440 U.K. ANÁLOGO SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (US$ THOUSAND)
CUADRO 441 U.K. H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 442 U.K. MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 443 U.K. ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED THOUSAND)
TABLE 444 U.K. BILE ACID " ABSORPERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 445 U.K. BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 446 U.K. TREATMENT SURGICAL " INTERVENTIONAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 447 U.K. INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 448 U.K. OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED THOUSAND)
TABLE 449 U.K. TRANSPLANTACIÓN INTESTINAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 450 U.K. EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 451 U.K. MEDICINA REGENERATIVO EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 452 U.K. MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 453 U.K. GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 454 U.K. TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 455 U.K. CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED THOUSAND)
CUADRO 456 U.K. SBS-IF EN TYPE 1 SBS-IF (SYNDROME BOWEL SYNDROME CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 457 U.K. TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
CUADRO 458 U.K. TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, POR PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 459 U.K. TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 460 U.K. INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 461 U.K. TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 462 U.K. TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 463 USD
TABLE 464 FRANCE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 465 FRANCE NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 466 FRANCE PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 467 FRANCE TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 468 FRANCE HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 469 FRANCE HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 470 FRANCE ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 471 FRANCE TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 472 FRANCE FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 473 FRANCE PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 474 MACRONUTRIENTES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 475 MICRONUTRIENTS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 476 FRANCE PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 477 FRANCE HORMONAL & INTESTINAL ADAPTATION THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 478 FRANCE GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 479 FRANCE GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 480 FRANCE IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 481 FRANCE ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 482 FRANCE OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 483 FRANCE ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 484 INHIBITORES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 485 ANÁLOGO SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE , 2018-2033 (USTED THOUSAND)
TABLE 486 FRANCE H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 487 FRANCE MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 488 FRANCE ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 489 FRANCE BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 490 SEQUESTRANTES DE BILE FRANCE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 491 FRANCE SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SYNDROME BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 492 PROCEDIMIENTOS DE LENGTHENING INTESTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 493 FRANCIA OSTOMY " RECONSTRUCCIÓN EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 494 FRANCE INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 495 FRANCE EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 496 FRANCE REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 497 FRANCE MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 498 FRANCE GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 499 FRANCE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 500 FRANCE CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 501 FRANCE SBS-IF ATTRIBUTABLE MARKET EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 502 FRANCE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 503 FRANCE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 504 FRANCE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 505 FRANCE INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 506 FRANCE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 507 FRANCE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 508 USD
TABLE 509 ITALY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 510 ITALY NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 511 ITALY PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 512 ITALIA TOTAL PARENTERAL NUTRITION (TPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 513 ITALY HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 514 ITALY HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 515 ITALIA ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 516 ITALIA TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 517 ITALY FORMULA TYPE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 518 ITALY PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 519 MACRONUTRIENTES ITALIA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 520 MICRONUTRIENTS ITALY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 521 ITALY PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 522 ITALIA HORMONAL " INTESTINAL ADAPTATION THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 523 ARMAS ITALIA GLP-2 EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 524 ITALY GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 525 IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 526 ITALY ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 527 ITALY OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 528 ITALIA ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 529 ITALY PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 530 ANÁLOGO DE SOMATOSTATINA EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE , 2018-2033 (US$ THOUSAND)
TABLE 531 ITALY H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 532 ITALY MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 533 ITALY ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 534 MODIFICADORES DE ABSORPTION ITALY BILE ACID EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 535 ITALY BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 536 TREATMENTO SURGICO " INTERVENTIONAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 537 PROCEDIMIENTOS ITALIAS DE LENGTHENING EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 538 OSTOMÍA DE ITALIA " RECONSTRUCCIÓN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 539 TRANSPLANTACIÓN ITALIA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 540 ITALIA EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 541 MEDICINA REGENERATIVO DE ITALIA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 542 ITALY MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 543 ITALY GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 544 ITALY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 545 ITALY CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 546 ITALY SBS-IF EN TYPE 1 SBS-IF (SYNDROME DE BOWEL DE SHORT con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 547 ITALY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 548 ITALY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 549 ITALY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 550 ITALIA INTRAVENOUS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 551 ITALY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 552 ITALY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 553 USD
CUADRO 554 ESPAÑA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
CUADRO 555 ESPAÑA NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 556 ESPAÑA PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 557 SPAIN TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 558 ESPAÑA HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 559 ESPAÑA HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 560 ESPAÑA ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 561 SPAIN TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 562 SPAIN FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 563 SPAIN PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 564 ESPAÑA MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 565 ESPAÑA MICRONUTRIENTS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 566 SPAIN PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 567 SPAIN HORMONAL ' INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 568 ESPAÑA GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 569 SPAIN GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 570 ESPAÑA IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 571 ESPAÑA ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 572 ESPAÑA OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 573 ESPAÑA ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 574 SPAIN PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 575 SPAIN SOMATOSTATIN ANALOGUES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 576 ESPAÑA H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 577 SPAIN MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 578 SPAIN ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 579 SPAIN BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 580 ESPAÑA BILE ACID SEQUESTRANTS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 581 SPAIN SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SYNDROME DE BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 582 SPAIN INTESTINAL LENGTHENING PROCEDURES EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 583 ESPAÑA OSTOMY " RECONSTRUCCIÓN EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 584 SPAIN INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 585 SPAIN EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 586 SPAIN REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 587 SPAIN MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 588 ESPAÑA GENE THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 589 SPAIN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 590 ESPAÑA CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 591 ESPAÑA SBS-IF MARKET ATTRIBUTABLE EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 592 ESPAÑA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
CUADRO 593 ESPAÑA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 594 ESPAÑA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 595 ESPAÑA INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 596 ESPAÑA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 597 ESPAÑA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 598 USD
CUADRO 599 TURKEY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 600 TURKEY NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 601 TURKEY PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 602 TURKEY TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 603 TURKEY HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 604 TURKEY HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
TABLE 605 TURKEY ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 606 TURKEY TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 607 TURKEY FORMULA TYPE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 608 TURKEY PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 609 MACRONUTRIENTES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 610 MICRONUTRIENTES DE TURQUÍA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 611 TURKEY PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 612 TURKEY HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 613 TURKEY GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 614 TURKEY GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
TABLE 615 TURKEY IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 616 TURKEY ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 617 TURKEY OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 618 TURKEY ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 619 TURKEY PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 620 TURKEY SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
TABLE 621 TURKEY H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 622 TURKEY MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 623 TURKEY ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 624 TURKEY BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 625 TURKEY BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 626 TURKEY SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 627 PROCEDIMIENTOS DE LENGTHENING INTESTINAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 628 TURKEY OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 629 TURKEY INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 630 TURKEY EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 631 TURKEY REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 632 TURKEY MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 633 TURKEY GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 634 TURKEY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 635 TURKEY CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 636 TURKEY SBS-IF EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 637 TURKEY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 638 TURKEY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 639 TURKEY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 640 TURQUÍA INTRAVENOUS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 641 TURKEY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 642 TURKEY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 643 USD
CUADRO 644 RUSSIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
CUADRO 645 RUSSIA NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 646 RUSSIA PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 647 RUSSIA TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 648 RUSSIA HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 649 RUSSIA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 650 RUSSIA ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 651 RUSSIA TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 652 RUSSIA FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 653 RUSSIA PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 654 RUSSIA MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 655 RUSSIA MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 656 RUSSIA PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 657 RUSSIA HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 658 RUSSIA GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 659 RUSSIA GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 660 RUSSIA IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 661 RUSSIA ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 662 RUSSIA OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 663 RUSSIA ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 664 RUSSIA PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 665 RUSSIA SOMATOSTATIN ANALOGUES EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 666 RUSSIA H2 RECEPTOR ANTAGONISTS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 667 RUSSIA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 668 RUSSIA ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 669 RUSSIA BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 670 RUSSIA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 671 RUSSIA SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 672 RUSSIA PROCEDIMIENTOS DE LENGTHENING INTESTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 673 RUSSIA OSTOMY " RECONSTRUCCIÓN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 674 RUSSIA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 675 RUSSIA EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 676 RUSSIA MEDICINA REGENERATIVO EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 677 RUSSIA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 678 RUSSIA GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 679 RUSSIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 680 RUSSIA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 681 RUSSIA SBS-IF MARKET ATTRIBUTABLE EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 682 RUSSIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
CUADRO 683 RUSSIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 684 RUSSIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 685 RUSSIA INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 686 RUSSIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 687 RUSSIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 688 USD
CUADRO 689 NETHERLANDS TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 690 NETHERLANDS NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 691 NETHERLANDS PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 692 NETHERLANDS TOTAL PARENTERAL NUTRITION (TPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 693 NETHERLANDS HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 694 NETHERLANDS HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 695 NETHERLANDS ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 696 NETHERLANDS TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 697 NETHERLANDS FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 698 NETHERLANDS PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 699 NETHERLANDS MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 700 NETHERLANDS MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 701 NETHERLANDS PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 702 NETHERLANDS HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 703 NETHERLANDS GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 704 NETHERLANDS GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 705 NETHERLANDS IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 706 NETHERLANDS ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 707 NETHERLANDS OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 708 NETHERLANDS ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 709 NETHERLANDS PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 710 NETHERLANDS SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 711 NETHERLANDS H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SYNDROME BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 712 NETHERLANDS MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 713 NETHERLANDS ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 714 NETHERLANDS BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 715 NETHERLANDS BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 716 NETHERLANDS SURGICAL ' INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 717 NETHERLANDS INTESTINAL LENGTHENING PROCEDURES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 718 NETHERLANDS OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 719 NETHERLANDS INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 720 NETHERLANDS EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 721 NETHERLANDS REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 722 NETHERLANDS MICROBIOME-BASED THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 723 NETHERLANDS GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 724 NETHERLANDS TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 725 NETHERLANDS CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 726 NETHERLANDS SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 727 NETHERLANDS TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
CUADRO 728 NETHERLANDS TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 729 NETHERLANDS TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 730 NETHERLANDS INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 731 NETHERLANDS TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 732 NETHERLANDS TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 733 USD
TABLE 734 SUIZA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 735 SWITZERLAND NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 736 SWITZERLAND PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 737 SWITZERLAND TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 738 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 739 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
TABLE 740 SWITZERLAND ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 741 SUIZA TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 742 SUIZA FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 743 SWITZERLAND PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 744 MACRONUTRIENTES DE SUIZA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 745 MICRONUTRIENTES DE SUIZA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 746 SWITZERLAND PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 747 SWITZERLAND HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 748 SWITZERLAND GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 749 SWITZERLAND GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
TABLE 750 SWITZERLAND IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 751 SWITZERLAND ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 752 SWITZERLAND OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 753 SWITZERLAND ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 754 SWITZERLAND PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 755 SWITZERLAND SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
TABLE 756 SWITZERLAND H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 757 SUPLEMENTACIÓN MICRONUTRIENT EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 758 SWITZERLAND ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 759 SWITZERLAND BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 760 SEQUESTRANTES DE SUIZA EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 761 SWITZERLAND SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 762 SWITZERLAND INTESTINAL LENGTHENING PROCEDURES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 763 OSTOMÍA DE SUIZA " RECONSTRUCCIÓN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 764 SWITZERLAND INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 765 SWITZERLAND EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 766 SWITZERLAND REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 767 SWITZERLAND MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 768 SWITZERLAND GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 769 SWITZERLAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 770 SWITZERLAND CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 771 SWITZERLAND SBS-IF EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 772 SWITZERLAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 773 SWITZERLAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 774 SWITZERLAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 775 SUIZA INTRAVENOUS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 776 SWITZERLAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 777 SWITZERLAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 778 USD
TABLE 779 BELGIUM TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 780 BELGIUM NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 781 BELGIUM PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 782 BELGIUM TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 783 BELGIUM HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 784 BELGIUM HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
TABLE 785 BELGIUM ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SYNDROME BOWEL BOWEL CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 786 BELGIUM TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 787 BELGIUM FORMULA TYPE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 788 BELGIUM PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 789 BELGIUM MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 790 MICRONUTRIENTS BELGIUM EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 791 BELGIUM PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 792 BELGIUM HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 793 ANALOGÍAS BELGIUM GLP-2 EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 794 BELGIUM GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
TABLE 795 BELGIUM IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL con FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 796 BELGIUM ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 797 BELGIUM OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 798 BELGIUM ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 799 INHIBITORES BELGIUM PROTONES EN TYPE 1 SBS-IF (SYNDROME DE BOWEL BOWEL CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 800 ANÁLOGO DE SOMATOSTATINA EN TYPE 1 SBS-IF (SYNDROME DE BOWEL BOWEL CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE , 2018-2033 (US$ THOUSAND)
TABLE 801 BELGIUM H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 802 BELGIUM MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME BOWEL BOWEL CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 803 BELGIUM ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SYNDROME BOWEL BOWEL CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED THOUSAND)
TABLE 804 BELGIUM BILE ACID " ABSORPERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 805 BELGIUM BILE ACID SEQUESTRANTS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 806 TREATMENTO SURGICANO BELGIUM EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 807 PROCEDIMIENTOS DE LENGTHENING BELGIUM EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 808 BELGIUM OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED THOUSAND)
TABLE 809 BELGIUM INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 810 BELGIUM EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 811 BELGIUM REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 812 BELGIUM MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 813 BELGIUM GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 814 BELGIUM TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 815 BELGIUM CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL BOWEL CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 816 BELGIUM SBS-IF EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 817 BELGIUM TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 818 BELGIUM TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 819 BELGIUM TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 820 BELGIUM INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 821 BELGIUM TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 822 BELGIUM TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 823 USD
TABLE 824 SWEDEN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 825 SWEDEN NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 826 SWEDEN PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 827 SWEDEN TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 828 SWEDEN HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 829 SWEDEN HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
TABLE 830 SWEDEN ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 831 SWEDEN TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 832 SWEDEN FORMULA TYPE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 833 SWEDEN PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 834 MACRONUTRIENTS SWEDEN EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 835 MICRONUTRIENTES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 836 SWEDEN PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 837 SWEDEN HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 838 SWEDEN GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 839 SWEDEN GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
TABLE 840 SWEDEN IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 841 SWEDEN ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 842 SWEDEN OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 843 SWEDEN ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 844 SWEDEN PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 845 SWEDEN SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
TABLE 846 SWEDEN H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 847 SUPLEMENTACIÓN MICRONUTRIENT EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED)
TABLE 848 SWEDEN ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 849 SWEDEN BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 850 SEQUESTRANTES DE BILLO SUIZO EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 851 SWEDEN SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 852 SWEDEN INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 853 SWEDEN OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 854 SUIZA INTESTINAL TRANSPLANTATION EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 855 SWEDEN EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 856 MEDICINA REGENERATIVO EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 857 SWEDEN MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 858 SWEDEN GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 859 SWEDEN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 860 SWEDEN CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 861 SWEDEN SBS-IF ATTRIBUTABLE MARKET EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 862 SWEDEN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 863 SWEDEN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 864 SWEDEN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 865 SWEDEN INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 866 SWEDEN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 867 SWEDEN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 868 USD
TABLE 869 DENMARK TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 870 DENMARK NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 871 DENMARK PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 872 DENMARK TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 873 DENMARK HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 874 DENMARK HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
TABLE 875 DENMARK ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 876 DENMARK TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 877 DENMARK FORMULA TYPE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 878 DENMARK PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 879 DENMARK MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 880 MICRONUTRIENTS DENMARK EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 881 DENMARK PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 882 DENMARK HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 883 DENMARK GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 884 DENMARK GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
TABLE 885 DENMARK IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 886 DENMARK ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 887 DENMARK OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 888 DENMARK ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 889 DENMARK PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 890 DENMARK SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
TABLE 891 DENMARK H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 892 DENMARK MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 893 DENMARK ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 894 DENMARK BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 895 ACID SEQUESTRANTS DENMARK EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 896 DENMARK SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 897 PROCEDIMIENTOS INTESTINALES DE LENGTHENING EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 898 DENMARK OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 899 DENMARK INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 900 DENMARK EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 901 DENMARK REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 902 DENMARK MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 903 DENMARK GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 904 DENMARK TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 905 DENMARK CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 906 DENMARK SBS-IF EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 907 DENMARK TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 908 DENMARK TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 909 DENMARK TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 910 DENMARK INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 911 DENMARK TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 912 DENMARK TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 913 USD
CUADRO 914 NORWAY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 915 NORWAY NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 916 NORWAY PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 917 NORWAY TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 918 NORWAY HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 919 NORWAY HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 920 NORUEGA ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 921 NORWAY TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 922 NORWAY FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 923 NORWAY PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 924 MACRONUTRIENTES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 925 MICRONUTRIENTS NORWAY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 926 NORWAY PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 927 NORWAY HORMONAL ' INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 928 NORWAY GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 929 NORWAY GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 930 NORWAY IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 931 NORWAY ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 932 NORWAY OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 933 NORWAY ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 934 INHIBITORES DE PUMP NORUEGA EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 935 ANÁLOGO SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE , 2018-2033 (US$ THOUSAND)
CUADRO 936 NORWAY H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 937 SUPLEMENTO MICRONUTRIENTE NORUEGA EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 938 NORWAY ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 939 NORWAY BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 940 NORWAY BILE ACID SEQUESTRANTS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 941 TREATMENTO SURGICO e INTERVENTIONAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 942 PROCEDIMIENTOS DE LENGTHENING NORWAY INTESTINAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 943 NORWAY OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 944 TRANSPLANTACIÓN INTESTINAL NORUEGA EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 945 THERAPIES NORWAY EMERGING " ADVANCED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 946 MEDICINA REGENERATIVO NORUEGA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 947 NORWAY MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 948 NORWAY GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 949 NORWAY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 950 NORWAY CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 951 NORWAY SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 952 NORWAY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 953 NORWAY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 954 TYPE NORWAY 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 955 NORWAY INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 956 NORWAY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 957 NORWAY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 958 USD
TABLE 959 FINLAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 960 FINLAND NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 961 FINLAND PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 962 FINLAND TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 963 FINLAND HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 964 FINLAND HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
TABLE 965 FINLAND ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 966 FINLAND TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 967 FINLAND FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 968 FINLAND PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 969 FINLAND MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 970 MICRONUTRIENTES FINLANDOS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 971 FINLAND PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 972 FINLAND HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 973 FINLAND GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 974 FINLAND GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
TABLE 975 FINLAND IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 976 FINLAND ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 977 FINLAND OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 978 FINLAND ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 979 FINLAND PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 980 FINLAND SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
TABLE 981 FINLAND H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 982 FINLAND MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 983 FINLAND ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 984 FINLAND BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 985 FINLAND BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 986 TREATMENTO SURGICO e INTERVENTIONAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 987 PROCEDIMIENTOS DE LENGTHENING FINLAND INTESTINAL EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 988 FINLAND OSTOMY " RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 989 FINLAND INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 990 FINLAND EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 991 FINLAND REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 992 FINLAND MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 993 FINLAND GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 994 FINLAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 995 FINLAND CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 996 FINLAND SBS-IF ATRIBUTABLE MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 997 FINLAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 998 FINLAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 999 FINLAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 1000 FINLAND INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1001 FINLAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 1002 FINLAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 1003 USD
TABLE 1004 REST OF EUROPE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 1005 REST OF EUROPE NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1006 REST OF EUROPE PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1007 REST OF EUROPE TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1008 REST OF EUROPE HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 1009 REST OF EUROPE HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
TABLE 1010 REST OF EUROPE ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1011 REST OF EUROPE TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1012 REST OF EUROPE FORMULA TYPE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1013 REST OF EUROPE PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1014 REST OF EUROPE MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1015 REST OF EUROPE MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1016 REST OF EUROPE PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1017 REST OF EUROPE HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1018 REST OF EUROPE GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1019 REST OF EUROPE GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
TABLE 1020 REST OF EUROPE IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1021 REST OF EUROPE ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1022 REST OF EUROPE OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1023 REST OF EUROPE ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1024 REST OF EUROPE PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1025 REST OF EUROPE SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
TABLE 1026 REST OF EUROPE H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1027 REST OF EUROPE MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1028 REST OF EUROPE ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1029 REST OF EUROPE BILE ACID & ABSORPERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1030 REST OF EUROPE BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1031 REST OF EUROPE SURGICAL & INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1032 REST OF EUROPE INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1033 REST OF EUROPE OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1034 REST OF EUROPE INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1035 REST OF EUROPE EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1036 REST OF EUROPE REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1037 REST OF EUROPE MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1038 REST OF EUROPE GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1039 REST OF EUROPE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 1040 REST OF EUROPE CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1041 REST OF EUROPE SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1042 REST OF EUROPE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 1043 REST OF EUROPE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 1044 REST OF EUROPE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 1045 REST OF EUROPE INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1046 REST OF EUROPE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 1047 REST OF EUROPE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 1048 ASIA-PACIFIC TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, 2018-2033 (USD THOUSAND)
TABLE 1049 ASIA-PACIFIC TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
CUADRO 1050 USD
TABLE 1051 ASIA-PACIFIC TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 1052 ASIA-PACIFIC NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1053 ASIA-PACIFIC PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1054 ASIA-PACIFIC TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1055 ASIA-PACIFIC HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 1056 ASIA-PACIFIC HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
TABLE 1057 ASIA-PACIFIC ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1058 ASIA-PACIFIC TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1059 ASIA-PACIFIC FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1060 ASIA-PACIFIC PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1061 ASIA-PACIFIC MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1062 MICRONUTRIENTES ASIA-PACIFICOS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1063 ASIA-PACIFIC PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1064 ASIA-PACIFIC HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1065 ASIA-PACIFIC GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1066 ASIA-PACIFIC GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 1067 ASIA-PACIFIC IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1068 ASIA-PACIFIC ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1069 ASIA-PACIFIC OPIOID-BASED EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1070 ASIA-PACIFIC ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1071 ASIA-PACIFIC PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1072 ASIA-PACIFIC SOMATOSTATIN ANALOGUES EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE , 2018-2033 (USTED)
TABLE 1073 ASIA-PACIFIC H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1074 ASIA-PACIFIC MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1075 ASIA-PACIFIC ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1076 ASIA-PACIFIC BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1077 ASIA-PACIFIC BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1078 ASIA-PACIFIC SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1079 PROCEDIMIENTOS DE LENGTHENING ASIA-PACIFIC INTESTINAL EN TYPE 1 SBS-IF (SYNDROME BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED)
CUADRO 1080 ASIA-PACIFIC OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1081 ASIA-PACIFIC INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1082 ASIA-PACIFIC EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1083 ASIA-PACIFIC REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1084 ASIA-PACIFIC MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1085 ASIA-PACIFIC GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1086 ASIA-PACIFIC TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 1087 ASIA-PACIFIC CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1088 ASIA-PACIFIC SBS-IF EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1089 ASIA-PACIFIC TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 1090 ASIA-PACIFIC TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 1091 ASIA-PACIFIC TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 1092 ASIA-PACIFIC INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1093 ASIA-PACIFIC TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 1094 ASIA-PACIFIC TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 1095 USD
TABLE 1096 JAPÓN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 1097 JAPÓN NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1098 JAPÓN PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1099 JAPÓN TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1100 JAPÓN HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1101 JAPÓN HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 1102 NUTRICIÓN ENTERAL DE JAPÓN (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1103 JAPÓN TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1104 JAPÓN FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1105 JAPÓN PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1106 MACRONUTRIENTES JAPÓN EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1107 MICRONUTRIENTS JAPÓN EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1108 JAPAN PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1109 JAPÓN HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1110 ARMAS JAPÓN GLP-2 EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1111 JAPAN GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 1112 JAPÓN IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1113 JAPAN ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1114 JAPAN OPIOID-BASED EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1115 JAPAN ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1116 INHIBITORES DE JAPÓN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (USTED)
CUADRO 1117 ANÁLOGO JAPÓN SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE , 2018-2033 (US$ THOUSAND)
TABLE 1118 JAPÓN H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1119 JAPÓN MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1120 JAPAN ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1121 JAPÓN BIL ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1122 JAPAN BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1123 TREATMENTO SURGICO Y INTERVENTIONAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1124 JAPÓN PROCEDIMIENTOS DE LENGTHENING INTESTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED)
CUADRO 1125 OSTOMÍA DE JAPÓN " RECONSTRUCCIÓN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1126 JAPAN INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1127 JAPÓN EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1128 JAPÓN MEDICINA REGENERATIVO EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1129 JAPAN MICROBIOME-BASED THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1130 JAPÓN GENE THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1131 JAPÓN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 1132 JAPAN CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1133 JAPÓN SBS-IF EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1134 JAPÓN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 1135 JAPÓN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 1136 JAPÓN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 1137 JAPÓN INTRAVENOUS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1138 JAPÓN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 1139 JAPÓN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 1140 USD
CUADRO 1141 CHINA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 1142 CHINA NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1143 CHINA PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1144 CHINA TOTAL PARENTERAL NUTRITION (TPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1145 CHINA HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1146 CHINA HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 1147 CHINA ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1148 CHINA TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1149 CHINA FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1150 CHINA PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1151 CHINA MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1152 MICRONUTRIENTS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1153 CHINA PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1154 CHINA HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1155 CHINA GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1156 CHINA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 1157 CHINA IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1158 CHINA ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1159 CHINA OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1160 CHINA ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1161 CHINA PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1162 ANÁLOGO DE CHINA SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE , 2018-2033 (US$ THOUSAND)
CUADRO 1163 CHINA H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1164 CHINA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1165 CHINA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1166 CHINA BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1167 CHINA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1168 CHINA SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1169 CHINA PROCEDIMIENTOS DE LENGTHENING INTESTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1170 CHINA OSTOMY " RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1171 CHINA TRANSPLANTATION INTESTINAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1172 CHINA EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1173 CHINA MEDICINA REGENERATIVE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1174 CHINA MICROBIOME-BASED THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1175 CHINA GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1176 CHINA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 1177 CHINA CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1178 CHINA SBS-IF MARKET ATTRIBUTABLE EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1179 CHINA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 1180 CHINA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1181 CHINA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 1182 CHINA INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1183 CHINA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 1184 CHINA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 1185 USD
TABLE 1186 SOUTH KOREA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 1187 SOUTH KOREA NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1188 SOUTH KOREA PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1189 SOUTH KOREA TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1190 SOUTH KOREA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 1191 SOUTH KOREA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 1192 SOUTH KOREA ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1193 SOUTH KOREA TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1194 SOUTH KOREA FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1195 SOUTH KOREA PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1196 MACRONUTRIENTES DE COREA SUR EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1197 MICRONUTRIENTES DEL SUR EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1198 SOUTH KOREA PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1199 SOUTH KOREA HORMONAL " INTESTINAL ADAPTATION THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1200 ARMAS SUR GLP-2 EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1201 SOUTH KOREA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
TABLE 1202 SOUTH KOREA IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1203 TILLO DE COREA ANTI-DIARRHEAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1204 SOUTH KOREA OPIOID-BASED IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1205 SOUTH KOREA ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1206 INHIBITORES DE PUMP DE COREA SUR EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1207 ANALOGOS SUR DE COREA SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE , 2018-2033 (US$ THOUSAND)
CUADRO 1208 SOUTH KOREA H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1209 SOUTH KOREA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1210 SOUTH KOREA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1211 SOUTH KOREA BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1212 SOUTH KOREA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1213 SOUTH KOREA SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1214 PROCEDIMIENTOS DE LENGTHENING INTESTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1215 SOUTH KOREA OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1216 DE SUR TRANSPLANTACIÓN INTESTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1217 SOUTH KOREA EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1218 SOUTH KOREA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1219 SOUTH KOREA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1220 SOUTH KOREA GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1221 SOUTH KOREA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 1222 SOUTH KOREA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1223 SOUTH KOREA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1224 SOUTH KOREA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 1225 SOUTH KOREA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 1226 SOUTH KOREA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 1227 SOUTH KOREA INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1228 SOUTH KOREA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 1229 SOUTH KOREA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 1230 USD
CUADRO 1231 INDIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 1232 INDIA NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1233 INDIA PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1234 INDIA TOTAL PARENTERAL NUTRITION (TPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1235 INDIA HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1236 INDIA HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 1237 INDIA ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1238 INDIA TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1239 INDIA FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1240 INDIA PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1241 INDIA MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1242 INDIA MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1243 INDIA PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1244 INDIA HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1245 INDIA GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1246 INDIA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 1247 INDIA IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1248 INDIA ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1249 INDIA OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1250 INDIA ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1251 INDIA PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1252 INDIA SOMATOSTATIN ANALOGUES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 1253 INDIA H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1254 INDIA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1255 INDIA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1256 INDIA BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1257 INDIA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1258 INDIA TREATMENTO SURGICO e INTERVENTIONAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1259 INDIA PROCEDIMIENTOS DE LENGTHENING INTESTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1260 INDIA OSTOMY " RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1261 TRANSPLANTACIÓN INTESTINAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1262 INDIA EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1263 INDIA MEDICINA REGENERATIVO EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1264 INDIA MICROBIOME-BASED THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1265 INDIA GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1266 INDIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 1267 INDIA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1268 INDIA SBS-IF MARKET ATTRIBUTABLE EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1269 INDIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 1270 INDIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1271 INDIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 1272 INDIA INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1273 INDIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 1274 INDIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 1275 USD
TABLE 1276 SINGAPORE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 1277 SINGAPORE NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1278 SINGAPORE PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1279 SINGAPORE TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1280 SINGAPORE HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 1281 SINGAPORE HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
TABLE 1282 SINGAPORE ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1283 SINGAPORE TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1284 SINGAPORE FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1285 SINGAPORE PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1286 MACRONUTRIENTES SINGAPORE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1287 MICRONUTRIENTES SINGAPORE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1288 SINGAPORE PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1289 SINGAPORE HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1290 SINGAPORE GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1291 SINGAPORE GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
TABLE 1292 SINGAPORE IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1293 SINGAPORE ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1294 SINGAPORE OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1295 SINGAPORE ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1296 INHIBITORES DE PUMP SINGAPORE EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1297 ANÁLOGO SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
TABLE 1298 SINGAPORE H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1299 SUPLEMENTO MICRONUTRIENTE SINGAPORE EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1300 SINGAPORE ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1301 SINGAPORE BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1302 SINGAPORE BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1303 TRATAMIENTO SURGICO " INTERVENTIONAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1304 PROCEDIMIENTOS INTESTINALES DE LENGTHENING EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1305 SINGAPORE OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1306 SINGAPORE TRANSPLANTACIÓN INTESTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1307 EMERGACION DE SINGAPORE " AVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1308 SINGAPORE REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1309 SINGAPORE MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1310 SINGAPORE GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1311 SINGAPORE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 1312 SINGAPORE CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1313 SINGAPORE SBS-IF EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1314 SINGAPORE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 1315 SINGAPORE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 1316 SINGAPORE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 1317 SINGAPORE INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1318 SINGAPORE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 1319 SINGAPORE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 1320 USD
TABLE 1321 THAILAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 1322 THAILAND NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1323 THAILAND PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1324 THAILAND TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1325 THAILAND HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 1326 THAILAND HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 1327 THAILAND ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1328 THAILAND TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1329 THAILAND FORMULA TYPE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1330 THAILAND PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1331 MACRONUTRIENTES DE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1332 MICRONUTRIENTS THAILAND EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1333 THAILAND PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1334 THAILAND HORMONAL & INTESTINAL ADAPTATION THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1335 ANÁLOGO GLP-2 THAILAND EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1336 THAILAND GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 1337 THAILAND IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1338 THAILAND ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1339 THAILAND OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1340 THAILAND ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1341 INHIBITORES DEL PROTOLETO DE THAILAND EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1342 ANÁLOGO SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
TABLE 1343 THAILAND H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1344 THAILAND MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1345 THAILAND ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1346 MODIFICADORES DE ABSORPCIÓN EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1347 THAILAND BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1348 THAILAND SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1349 THAILAND INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1350 OSTOMÍA " RECONSTRUCCIÓN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED THOUSAND)
CUADRO 1351 TRANSPLANTACIÓN INTESTINAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1352 THAILAND EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1353 THAILAND REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1354 THAILAND MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1355 THAILAND GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1356 THAILAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 1357 THAILAND CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1358 THAILAND SBS-IF ATTRIBUTABLE MARKET EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1359 THAILAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 1360 THAILAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 1361 THAILAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 1362 THAILAND INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1363 THAILAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 1364 THAILAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 1365 USD
CUADRO 1366 INDONESIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 1367 INDONESIA NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1368 INDONESIA PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1369 INDONESIA TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1370 INDONESIA HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1371 INDONESIA HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 1372 INDONESIA ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1373 INDONESIA TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1374 INDONESIA FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1375 INDONESIA PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1376 INDONESIA MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1377 INDONESIA MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1378 INDONESIA PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1379 INDONESIA HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1380 INDONESIA GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1381 INDONESIA GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 1382 INDONESIA IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1383 INDONESIA ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1384 INDONESIA OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1385 INDONESIA ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1386 INDONESIA PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1387 INDONESIA SOMATOSTATIN ANALOGUES EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (US$ THOUSAND)
CUADRO 1388 INDONESIA H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1389 INDONESIA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1390 INDONESIA ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1391 INDONESIA BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1392 INDONESIA BILE ACID SEQUESTRANTS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1393 INDONESIA SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1394 INDONESIA PROCEDIMIENTOS DE LENGTHENING INTESTINAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1395 INDONESIA OSTOMY " RECONSTRUCCIÓN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1396 INDONESIA TRANSPLANTACIÓN INTESTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1397 INDONESIA EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1398 INDONESIA MEDICINA REGENERATIVO EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1399 INDONESIA MICROBIOME-BASED THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1400 INDONESIA GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1401 INDONESIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 1402 INDONESIA CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1403 INDONESIA SBS-IF MARKET ATTRIBUTABLE EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1404 INDONESIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
CUADRO 1405 INDONESIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1406 INDONESIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 1407 INDONESIA INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1408 INDONESIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 1409 INDONESIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 1410 USD
CUADRO 1411 MALAYSIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
CUADRO 1412 MALAYSIA NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1413 MALAYSIA PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1414 MALAYSIA TOTAL PARENTERAL NUTRITION (TPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1415 MALAYSIA HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1416 MALAYSIA HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 1417 MALAYSIA ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1418 MALAYSIA TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1419 MALAYSIA FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1420 MALAYSIA PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1421 MALAYSIA MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1422 MALAYSIA MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1423 MALAYSIA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1424 MALAYSIA HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1425 MALAYSIA GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1426 MALAYSIA GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 1427 MALAYSIA IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1428 MALAYSIA ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1429 MALAYSIA OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1430 MALAYSIA ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1431 MALAYSIA PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1432 MALAYSIA SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 1433 MALAYSIA H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1434 MALAYSIA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1435 MALAYSIA ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1436 MALAYSIA BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1437 MALAYSIA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1438 MALAYSIA SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1439 MALAYSIA INTESTINAL LENGTHENING PROCEDURES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1440 MALAYSIA OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1441 MALAYSIA TRANSPLANTACIÓN INTESTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1442 MALAYSIA EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1443 MALAYSIA MEDICINA REGENERATIVO EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1444 MALAYSIA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1445 MALAYSIA GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1446 MALAYSIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 1447 MALAYSIA CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1448 MALAYSIA SBS-IF EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1449 MALAYSIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
CUADRO 1450 MALAYSIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, POR PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1451 MALAYSIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 1452 MALAYSIA INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1453 MALAYSIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 1454 MALAYSIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 1455 USD
TABLE 1456 PHILIPPINES TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
CUADRO 1457 PHILIPPINES NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1458 PHILIPPINES PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1459 PHILIPPINES TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1460 PHILIPPINES HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1461 PHILIPPINES HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 1462 PHILIPPINES ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1463 PHILIPPINES TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1464 PHILIPPINES FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1465 PHILIPPINES PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1466 PHILIPPINES MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1467 PHILIPPINES MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1468 PHILIPPINES PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1469 PHILIPPINES HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1470 PHILIPPINES GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1471 PHILIPPINES GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 1472 PHILIPPINES IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1473 PHILIPPINES ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1474 PHILIPPINES OPIOID-BASED IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1475 PHILIPPINES ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1476 PHILIPPINES PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1477 PHILIPPINES SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 1478 PHILIPPINES H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1479 PHILIPPINES MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1480 PHILIPPINES ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1481 PHILIPPINES BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1482 PHILIPPINES BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1483 PHILIPPINES SURGICAL ' INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1484 PHILIPPINES INTESTINAL LENGTHENING PROCEDURES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1485 PHILIPPINES OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1486 PHILIPPINES INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1487 PHILIPPINES EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1488 PHILIPPINES REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1489 PHILIPPINES MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1490 PHILIPPINES GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1491 PHILIPPINES TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 1492 PHILIPPINES CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1493 PHILIPPINES SBS-IF EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1494 PHILIPPINES TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 1495 PHILIPPINES TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1496 PHILIPPINES TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 1497 PHILIPPINES INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1498 PHILIPPINES TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 1499 PHILIPPINES TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 1500 USD
TABLE 1501 BELGIUM TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 1502 BELGIUM NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1503 BELGIUM PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1504 BELGIUM TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1505 BELGIUM HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 1506 BELGIUM HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 1507 NUTRICIÓN ENTERAL BELGIUM (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL BOWEL CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1508 BELGIUM TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1509 BELGIUM FORMULA TYPE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1510 BELGIUM PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1511 BELGIUM MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1512 MICRONUTRIENTES BELGIUM EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO DE PHARMACOLOGÍA DE BELGIUM 1513 EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1514 BELGIUM HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1515 BELGIUM GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1516 BELGIUM GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USTED)
CUADRO 1517 BELGIUM IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1518 BELGIUM ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1519 BELGIUM OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1520 BELGIUM ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1521 BELGIUM PROTON INHIBITORS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL BOWEL CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1522 ANÁLOGO SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL BOWEL CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE , 2018-2033 (US$ THOUSAND)
TABLE 1523 BELGIUM H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1524 MICRONUTRIENTE BELGIUM SUPPLEMENTATION EN TYPE 1 SBS-IF (SYNDROME DE BOWEL BOWEL CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1525 BELGIUM ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SYNDROME BOWEL BOWEL CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED THOUSAND)
TABLE 1526 BELGIUM BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1527 BELGIUM BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SYNDROME BOWEL BOWEL CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1528 TREATMENTO SURGICO e INTERVENTIONAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1529 BELGIUM INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1530 BELGIUM OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED)
TABLE 1531 BELGIUM INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1532 BELGIUM EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1533 BELGIUM REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1534 BELGIUM MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1535 BELGIUM GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1536 BELGIUM TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 1537 BELGIUM CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL BOWEL CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1538 BELGIUM SBS-IF MARKET ATTRIBUTABLE EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1539 BELGIUM TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 1540 BELGIUM TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 1541 BELGIUM TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 1542 BELGIUM INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1543 BELGIUM TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 1544 BELGIUM TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 1545 USD
CUADRO 1546 NEW ZEALAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
CUADRO 1547 NEW ZEALAND NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1548 NUEVA ZELANDA PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1549 NUEVA ZELANDA TOTAL PARENTERAL NUTRITION (TPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1550 NEW ZEALAND HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1551 NEW ZEALAND HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 1552 NUEVA ZELANDA ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED THOUSAND)
CUADRO 1553 NEW ZEALAND TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1554 NEW ZEALAND FORMULA TYPE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1555 NEW ZEALAND PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1556 NUEVO ZEALAND MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1557 NUEVAS MICRONUTRIENTES DE ZELANDA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1558 NEW ZEALAND PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1559 NEW ZEALAND HORMONAL " INTESTINAL ADAPTATION THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL con FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED)
CUADRO 1560 NUEVA ZELANDA GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1561 NEW ZEALAND GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 1562 NUEVA ZELANDA IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED THOUSAND)
CUADRO 1563 NEW ZEALAND ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1564 NUEVA ZELANDA OPIOID-BASED EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1565 NUEVA ZEALANDA ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1566 NUEVOS INHIBITORES DE PUMP DE ZELANDA EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1567 NUEVA ZELANDA ANÁLOGO SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, POR TYPE , 2018-2033 (US$ THOUSAND)
CUADRO 1568 NUEVA ZEALANDA H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED THOUSAND)
CUADRO 1569 NUEVA SUPLEMENTACIÓN MICRONUTRIENTE DE ZELANDA EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1570 NEW ZEALAND ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1571 NUEVA ZEALANDA BILE ACID & ABSORPERS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1572 NUEVO ZEALAND BILE ACID SEQUESTRANTS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1573 NEW ZEALAND SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1574 NUEVAS PROCEDIMIENTOS DE LENGTHENING INTESTINAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1575 NUEVA ZELANDA OSTOMY " RECONSTRUCCIÓN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED)
CUADRO 1576 NEW ZEALAND INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1577 NEW ZEALAND EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1578 NEW ZEALAND REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1579 NEW ZEALAND MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1580 NEW ZEALAND GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1581 NEW ZEALAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 1582 NEW ZEALAND CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1583 NEW ZEALAND SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1584 NEW ZEALAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
CUADRO 1585 NEW ZEALAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1586 NEW ZEALAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 1587 NUEVA ZELANDA INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1588 NEW ZEALAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 1589 NEW ZEALAND TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 1590 USD
TABLE 1591 HONG KONG TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 1592 HONG KONG NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1593 HONG KONG PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1594 HONG KONG TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1595 HONG HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 1596 HONG HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 1597 HONG KONG ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED THOUSAND)
TABLE 1598 HONG TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1599 HONG FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1600 HONG KONG PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1601 HONG KONG MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1602 HONG MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1603 HONG KONG PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1604 HONG KONG HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1605 HONG KONG GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1606 HONG KONG GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 1607 HONG KONG IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1608 HONG KONG ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1609 HONG KONG OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1610 HONG KONG ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1611 HONG KONG PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED)
CUADRO 1612 HONG SOMATOSTATIN ANALOGUES EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 1613 HONG H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1614 HONG KONG MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1615 HONG KONG ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1616 HONG BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1617 HONG KONG BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1618 HONG KONG SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1619 HONG KONG INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1620 HONG OSTOMY " RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1621 HONG KONG INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1622 HONG KONG EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1623 HONG KONG REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1624 HONG MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1625 HONG KONG GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1626 HONG KONG TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 1627 HONG KONG CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1628 HONG KONG SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1629 HONG KONG TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 1630 HONG KONG TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 1631 HONG KONG TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 1632 HONG INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1633 HONG KONG TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 1634 HONG KONG TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 1635 USD
TABLE 1636 TAIWAN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 1637 TAIWAN NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1638 TAIWAN PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1639 TAIWAN TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1640 TAIWAN HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 1641 TAIWAN HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 1642 TAIWAN ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1643 TAIWAN TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1644 TAIWAN FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1645 TAIWAN PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1646 TAIWAN MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1647 TAIWAN MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1648 TAIWAN PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1649 TAIWAN HORMONAL " INTESTINAL ADAPTATION THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (USTED)
TABLE 1650 TAIWAN GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1651 TAIWAN GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 1652 TAIWAN IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1653 TAIWAN ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1654 TAIWAN OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1655 TAIWAN ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1656 TAIWAN PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1657 TAIWAN SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 1658 TAIWAN H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1659 TAIWAN MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1660 TAIWAN ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1661 TAIWAN BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1662 TAIWAN BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1663 TAIWAN SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1664 TAIWAN INTESTINAL LENGTHENING PROCEDURES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1665 TAIWAN OSTOMY " RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED THOUSAND)
TABLE 1666 TAIWAN INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1667 TAIWAN EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1668 TAIWAN REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1669 TAIWAN MICROBIOME-BASED THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1670 TAIWAN GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1671 TAIWAN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 1672 TAIWAN CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1673 TAIWAN SBS-IF MARKET ATTRIBUTABLE EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1674 TAIWAN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 1675 TAIWAN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1676 TAIWAN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 1677 TAIWAN INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1678 TAIWAN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 1679 TAIWAN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 1680 USD
CUADRO 1681 REST OF ASIA-PACIFIC TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
CUADRO 1682 REST OF ASIA-PACIFIC NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1683 REST OF ASIA-PACIFIC PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1684 REST OF ASIA-PACIFIC TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1685 REST OF ASIA-PACIFIC HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1686 REST OF ASIA-PACIFIC HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 1687 REST OF ASIA-PACIFIC ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1688 REST OF ASIA-PACIFIC TUBE FEEDING IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1689 REST OF ASIA-PACIFIC FORMULA TYPE IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1690 REST OF ASIA-PACIFIC PN COMPOSITION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1691 REST OF ASIA-PACIFIC MACRONUTRIENTS IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1692 REST OF ASIA-PACIFIC MICRONUTRIENTS IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1693 REST OF ASIA-PACIFIC PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1694 REST OF ASIA-PACIFIC HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1695 REST OF ASIA-PACIFIC GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1696 REST OF ASIA-PACIFIC GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 1697 REST OF ASIA-PACIFIC IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1698 REST OF ASIA-PACIFIC ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1699 REST OF ASIA-PACIFIC OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1700 REST OF ASIA-PACIFIC ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1701 REST OF ASIA-PACIFIC PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1702 REST OF ASIA-PACIFIC SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 1703 REST OF ASIA-PACIFIC H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1704 REST OF ASIA-PACIFIC MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1705 REST OF ASIA-PACIFIC ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1706 REST OF ASIA-PACIFIC BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1707 REST OF ASIA-PACIFIC BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1708 REST OF ASIA-PACIFIC SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1709 REST OF ASIA-PACIFIC INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1710 REST OF ASIA-PACIFIC OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1711 REST OF ASIA-PACIFIC INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1712 REST OF ASIA-PACIFIC EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1713 REST OF ASIA-PACIFIC REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1714 REST OF ASIA-PACIFIC MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1715 REST OF ASIA-PACIFIC GENE THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1716 REST OF ASIA-PACIFIC TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 1717 REST OF ASIA-PACIFIC CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1718 REST OF ASIA-PACIFIC SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1719 REST OF ASIA-PACIFIC TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 1720 REST OF ASIA-PACIFIC TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1721 REST OF ASIA-PACIFIC TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 1722 REST OF ASIA-PACIFIC INTRAVENOUS IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1723 REST OF ASIA-PACIFIC TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 1724 REST OF ASIA-PACIFIC TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 1725 SOUTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, 2018-2033 (USD THOUSAND)
TABLE 1726 SOUTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
CUADRO 1727 USD
TABLE 1728 SOUTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 1729 SOUTH AMERICA NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1730 SOUTH AMERICA PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1731 SOUTH AMERICA TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1732 SOUTH AMERICA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 1733 SOUTH AMERICA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 1734 NUTRICIÓN ENTERAL SURÉRICA (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1735 SOUTH AMERICA TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1736 SOUTH AMERICA FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1737 COMPOSICIÓN PN SOUTH AMERICA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1738 MACRONUTRIENTES SUR AMERICA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1739 MICRONUTRIENTES SOUTH AMERICA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1740 SOUTH AMERICA PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1741 SOUTH AMERICA HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1742 ANALOGOS SUR AMERICA GLP-2 EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (USTED THOUSAND)
TABLE 1743 SOUTH AMERICA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 1744 SOUTH AMERICA IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1745 SUR AMERICA ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1746 SOUTH AMERICA OPIOID-BASED EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1747 SOUTH AMERICA ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1748 INHIBITORES SUR AMERICA PROTON EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1749 ANÁLOGO SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 1750 ANTAGONISTAS H2 RECEPTOR EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1751 SUR AMERICA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1752 SOUTH AMERICA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1753 SUR AMERICA BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1754 SOUTH AMERICA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1755 SURGICA SUR AMERICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1756 PROCEDIMIENTOS DE LENGTHENING INTESTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1757 SOUTH AMERICA OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1758 TRANSPLANTACIÓN INTESTINAL SUR AMERICA EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1759 SUR AMERICA EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1760 SOUTH AMERICA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1761 SOUTH AMERICA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1762 SOUTH AMERICA GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1763 SUR AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 1764 SOUTH AMERICA CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1765 SOUTH AMERICA SBS-IF EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1766 SOUTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 1767 SOUTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1768 SOUTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 1769 SOUTH AMERICA INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1770 SOUTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 1771 SOUTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 1772 USD
TABLE 1773 BRASIL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
CUADRO 1774 BRAZIL NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1775 BRAZIL PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1776 BRAZIL TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1777 BRAZIL HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1778 BRASIL HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 1779 BRAZIL ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1780 BRASIL TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1781 BRASIL FORMULA TYPE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1782 BRAZIL PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1783 MACRONUTRIENTES BRASIL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1784 MICRONUTRIENTS BRASIL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1785 BRAZIL PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1786 BRAZIL HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1787 BRAZIL GLP-2 ANÁLOGO EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1788 BRAZIL GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 1789 BRAZIL IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1790 BRAZIL ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1791 BRASIL OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1792 BRAZIL ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1793 BRASIL PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1794 ANÁLOGO BRASIL SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE , 2018-2033 (US$ THOUSAND)
TABLE 1795 BRAZIL H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1796 SUPLEMENTO DE MICRONUTRIENTE BRASIL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1797 BRAZIL ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1798 BRASIL BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1799 SEQUESTRANTES BRASIL BILE ACID EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1800 BRAZIL SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1801 BRAZIL INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1802 BRASIL OSTOMY " RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1803 BRAZIL INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1804 BRASIL EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1805 BRAZIL REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1806 BRAZIL MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1807 BRAZIL GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1808 BRASIL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 1809 BRASIL CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1810 BRASIL SBS-IF EN TYPE 1 SBS-IF (SYNDROME DE BOWEL DE SHORT con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1811 BRAZIL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 1812 BRASIL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1813 BRASIL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 1814 BRAZIL INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1815 BRASIL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 1816 BRASIL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 1817 USD
CUADRO 1818 ARGENTINA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 1819 ARGENTINA NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1820 ARGENTINA PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1821 ARGENTINA TOTAL PARENTERAL NUTRITION (TPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1822 ARGENTINA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1823 ARGENTINA HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 1824 ARGENTINA ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1825 ARGENTINA TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1826 ARGENTINA FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1827 ARGENTINA PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1828 ARGENTINA MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1829 ARGENTINA MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1830 ARGENTINA PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1831 ARGENTINA HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1832 ARGENTINA GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1833 ARGENTINA GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USTED)
CUADRO 1834 ARGENTINA IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1835 ARGENTINA ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1836 ARGENTINA OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1837 ARGENTINA ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1838 ARGENTINA PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1839 ARGENTINA SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 1840 ARGENTINA H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1841 ARGENTINA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1842 ARGENTINA ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1843 ARGENTINA BILE ACID " ABSORPERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1844 ARGENTINA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1845 ARGENTINA SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1846 ARGENTINA PROCEDIMIENTOS DE LENGTHENING INTESTINAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1847 ARGENTINA OSTOMY " RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1848 ARGENTINA TRANSPLANTACIÓN INTESTINAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1849 ARGENTINA EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1850 ARGENTINA REGENERATIVE MEDICINE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1851 ARGENTINA MICROBIOME-BASED THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1852 ARGENTINA GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1853 ARGENTINA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 1854 ARGENTINA CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1855 ARGENTINA SBS-IF EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1856 ARGENTINA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
CUADRO 1857 ARGENTINA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, POR PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1858 ARGENTINA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 1859 ARGENTINA INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1860 ARGENTINA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 1861 ARGENTINA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 1862 USD
TABLE 1863 COLOMBIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 1864 COLOMBIA NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1865 COLOMBIA PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1866 COLOMBIA TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1867 COLOMBIA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1868 COLOMBIA HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 1869 COLOMBIA ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1870 COLOMBIA TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1871 COLOMBIA FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1872 COLOMBIA PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1873 COLOMBIA MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1874 COLOMBIA MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1875 COLOMBIA PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1876 COLOMBIA HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1877 COLOMBIA GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1878 COLOMBIA GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 1879 COLOMBIA IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1880 COLOMBIA ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1881 COLOMBIA OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1882 COLOMBIA ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1883 COLOMBIA PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1884 ANÁLOGO COLOMBIA SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE , 2018-2033 (US$ THOUSAND)
CUADRO 1885 COLOMBIA H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1886 COLOMBIA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1887 COLOMBIA ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1888 COLOMBIA BILE ACID & ABSORPERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1889 COLOMBIA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1890 COLOMBIA SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1891
TABLE 1892 COLOMBIA PROCEDIMIENTOS DE LENGTHENING INTESTINAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1893 COLOMBIA OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1894 COLOMBIA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1895 COLOMBIA EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1896 COLOMBIA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1897 COLOMBIA MICROBIOME-BASED THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1898 COLOMBIA GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1899 COLOMBIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 1900 COLOMBIA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1901 COLOMBIA SBS-IF MARKET ATTRIBUTABLE EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1902 COLOMBIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 1903 COLOMBIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1904 COLOMBIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 1905 COLOMBIA INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1906 COLOMBIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 1907 COLOMBIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 1908 USD
CUADRO 1909 CHILE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 1910 CHILE NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1911 CHILE PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1912 CHILE TOTAL PARENTERAL NUTRITION (TPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1913 CHILE HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1914 CHILE HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 1915 CHILE ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1916 CHILE TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1917 CHILE FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1918 CHILE PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1919 MACRONUTRIENTS CHILE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1920 MICRONUTRIENTS CHILE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1921 THERAPY CHILE PHARMACOLOGICAL EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED THOUSAND)
CUADRO 1922 CHILE HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1923 ANALOGOS CHILE GLP-2 EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1924 CHILE GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USTED)
CUADRO 1925 NILE IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1926 CHILE ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1927 CHILE OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1928 CHILE ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1929 INHIBITORES DE PUMP CHILE EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1930 ANÁLOGO DE SOMATOSTATINA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 1931 CHILE H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1932 SUPLEMENTO MICRONUTRIENTE CHILE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1933 CHILE ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1934 MODIFICADORES DE ACID " ABSORPTION EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1935 CHILE BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1936 TRATAMIENTO SURGICO Y INTERVENTIONAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1937 PROCEDIMIENTOS DE LENGTHENING CHILE INTESTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1938 CHILE OSTOMY " RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1939 TRANSPLANTACIÓN INTESTINAL CHILE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO DE 1940 TERAPÍAS DE EMERGACIÓN DE CHILE EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (USTED)
CUADRO 1941 MEDICINA REGENERATIVO CHILE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1942 Terapia INFANTIL DE MICROBIOME EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL)
TABLE 1943 CHILE GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1944 CHILE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 1945 CHILE CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1946 CHILE SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1947 CHILE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 1948 CHILE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1949 CHILE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 1950 CHILE INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1951 CHILE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 1952 CHILE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 1953 USD
TABLE 1954 PERU TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 1955 PERU NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1956 PERU PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1957 PERU TOTAL PARENTERAL NUTRITION (TPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1958 PERU HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1959 PERU HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO DE 1960 NUTRICIÓN PERU ENTERAL (EN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1961 PERU TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1962 PERU FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1963 PERU PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1964 PERU MACRONUTRIENTS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1965 PERU MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1966 PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1967 PERU HORMONAL " INTESTINAL ADAPTATION THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1968 PERU GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1969 PERU GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 1970 PERU IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1971 PERU ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1972 PERU OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1973 PERU ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO DE PROTOLETO DE PERU 1974 INHIBITORES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1975 PERU SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
TABLE 1976 PERU H2 RECEPTOR ANTAGONISTS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1977 PERU MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1978 PERU ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1979 PERU BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO DE 1980 PALABRAS DE ACID EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 1981 TREATMENTO PERU SURGICO e INTERVENTIONAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED THOUSAND)
CUADRO DE 1982 PROCEDIMIENTOS DE LENGTHENING PERUTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL)
CUADRO 1983 PERU OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO DE 1984 TRANSPLANTACIÓN PERUTIVA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1985 PERU EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1986 PERU REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1987 PERU MICROBIOME-BASED THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1988 PERU GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 1989 PERU TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 1990 PERU CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO DE 1991 PERU SBS-IF MARKET ATTRIBUTABLE EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 1992 PERU TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
CUADRO 1993 PERU TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 1994 PERU TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 1995 PERU INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 1996 PERU TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 1997 PERU TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO DE 1998
TABLE 1999 ECUADOR TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 2000 ECUADOR NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2001 ECUADOR PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2002 ECUADOR TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2003 ECUADOR HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2004 ECUADOR HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
TABLE 2005 ECUADOR ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2006 ECUADOR TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2007 ECUADOR FORMULA TYPE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO DE ECUADOR PN COMPOSITION EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2009 ECUADOR MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2010 ECUADOR MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2011 ECUADOR PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2012 ECUADOR HORMONAL " INTESTINAL ADAPTATION THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2013 ECUADOR GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2014 ECUADOR GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
TABLE 2015 ECUADOR IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2016 ECUADOR ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2017 ECUADOR OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2018 ECUADOR ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2019 ECUADOR PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2020 ECUADOR SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
TABLE 2021 ECUADOR H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2022 ECUADOR MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2023 ECUADOR ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2024 ECUADOR BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2025 ECUADOR BILE ACID SEQUESTRANTS EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2026 ECUADOR SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2027 ECUADOR PROCEDIMIENTOS DE LENGTHENING INTESTINAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2028 CUADOR OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2029 ECUADOR TRANSPLANTATION INTESTINAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2030 ECUADOR EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2031 MEDICINA REGENERATIVO ECUADOR EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2032 ECUADOR MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2033 ECUADOR GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2034 ECUADOR TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 2035 ECUADOR CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2036 ECUADOR SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2037 ECUADOR TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 2038 ECUADOR TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2039 ECUADOR TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 2040 ECUADOR INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2041 ECUADOR TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 2042 ECUADOR TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 2043 USD
TABLE 2044 URUGUAY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 2045 URUGUAY NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2046 URUGUAY PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2047 URUGUAY TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2048 URUGUAY HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2049 URUGUAY HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
TABLE 2050 URUGUAY ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2051 URUGUAY TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2052 URUGUAY FORMULA TYPE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2053 URUGUAY PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2054 URUGUAY MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2055 URUGUAY MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2056 URUGUAY PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2057 URUGUAY HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2058 URUGUAY GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2059 URUGUAY GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
TABLE 2060 URUGUAY IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2061 URUGUAY ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2062 URUGUAY OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2063 URUGUAY ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2064 URUGUAY PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2065 URUGUAY SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
TABLE 2066 URUGUAY H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED)
TABLE 2067 URUGUAY MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2068 URUGUAY ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2069 URUGUAY BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2070 URUGUAY BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2071 TREATMENTO SURGICANO URUGUAY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2072 URUGUAY INTESTINAL LENGTHENING PROCEDURES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2073 URUGUAY OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2074 URUGUAY INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2075 URUGUAY EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2076 URUGUAY REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2077 URUGUAY MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2078 URUGUAY GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2079 URUGUAY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 2080 URUGUAY CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2081 URUGUAY SBS-IF EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2082 URUGUAY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 2083 URUGUAY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2084 URUGUAY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 2085 URUGUAY INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2086 URUGUAY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 2087 URUGUAY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 2088 USD
TABLE 2089 VENEZUELA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 2090 VENEZUELA NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2091 VENEZUELA PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2092 VENEZUELA TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2093 VENEZUELA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2094 VENEZUELA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
TABLE 2095 VENEZUELA ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2096 VENEZUELA TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2097 VENEZUELA FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2098 VENEZUELA PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2099 VENEZUELA MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2100 VENEZUELA MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2101 VENEZUELA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2102 VENEZUELA HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2103 VENEZUELA GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2104 VENEZUELA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 2105 VENEZUELA IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2106 VENEZUELA ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2107 VENEZUELA OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2108 VENEZUELA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2109 VENEZUELA PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2110 VENEZUELA SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 2111 VENEZUELA H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2112 VENEZUELA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2113 VENEZUELA ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2114 VENEZUELA BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2115 VENEZUELA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2116 VENEZUELA SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2117 VENEZUELA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2118 VENEZUELA OSTOMY " RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2119 VENEZUELA TRANSPLANTATION INTESTINAL EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2120 VENEZUELA EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2121 VENEZUELA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2122 VENEZUELA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2123 VENEZUELA GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2124 VENEZUELA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 2125 VENEZUELA CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2126 VENEZUELA SBS-IF EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2127 VENEZUELA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 2128 VENEZUELA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2129 VENEZUELA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 2130 VENEZUELA INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2131 VENEZUELA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 2132 VENEZUELA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 2133 USD
CUADRO 2134 BOLIVIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 2135 BOLIVIA NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2136 BOLIVIA PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2137 BOLIVIA TOTAL PARENTERAL NUTRITION (TPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2138 BOLIVIA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2139 BOLIVIA HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 2140 BOLIVIA ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2141 BOLIVIA TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2142 BOLIVIA FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2143 BOLIVIA PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2144 MACRONUTRIENTES BOLIVIA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2145 MICRONUTRIENTS BOLIVIA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2146 BOLIVIA PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED)
CUADRO 2147 BOLIVIA HORMONAL " INTESTINAL ADAPTATION THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL con FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED)
CUADRO 2148 BOLIVIA GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2149 BOLIVIA GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USTED)
CUADRO 2150 BOLIVIA IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2151 Terapia de BOLIVIA ANTI-DIARRHEAL EN TYPE 1 SBS-IF (SYNDROME DE SHORT con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2152 BOLIVIA OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2153 ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2154 BOLIVIA PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2155 BOLIVIA SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 2156 BOLIVIA H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2157 BOLIVIA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2158 BOLIVIA ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2159 BOLIVIA BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2160 BOLIVIA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2161 TREATMENTO SURGICO e INTERVENTIONAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2162 BOLIVIA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2163 BOLIVIA OSTOMY " RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2164 TRANSPLANTACIÓN INTESTINAL DE BOLIVIA EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2165 BOLIVIA EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2166 BOLIVIA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2167 BOLIVIA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2168 BOLIVIA GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2169 BOLIVIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 2170 BOLIVIA CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2171 BOLIVIA SBS-IF EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2172 BOLIVIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
CUADRO 2173 BOLIVIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2174 BOLIVIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 2175 BOLIVIA INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2176 BOLIVIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 2177 BOLIVIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 2178 USD
TABLE 2179 PARAGUAY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
CUADRO 2180 PARAGUAY NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2181 PARAGUAY PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2182 PARAGUAY TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2183 PARAGUAY HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2184 PARAGUAY HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 2185 PARAGUAY ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2186 PARAGUAY TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2187 PARAGUAY FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2188 PARAGUAY PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2189 PARAGUAY MACRONUTRIENTS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2190 MICRONUTRIENTS PARAGUAY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2191 PARAGUAY PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2192 PARAGUAY HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2193 PARAGUAY GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2194 PARAGUAY GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 2195 PARAGUAY IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2196 PARAGUAY THERAPY ANTI-DIARRHEAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2197 PARAGUAY OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2198 PARAGUAY ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2199 INHIBITORES PARAGUAY PUMP EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2200 PARAGUAY ANÁLOGO SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE , 2018-2033 (US$ THOUSAND)
CUADRO 2201 PARAGUAY H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2202 PARAGUAY MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2203 PARAGUAY ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2204 PARAGUAY BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2205 SEQUESTRANTES DE ACID PARAGUAY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2206 PARAGUAY TREATMENTO SURGICO " INTERVENTIONAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2207 PARAGUAY PROCEDIMIENTOS DE LENGTHENING INTESTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2208 PARAGUAY OSTOMY " RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2209 PARAGUAY TRANSPLANTACIÓN INTESTINAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2210 PARAGUAY EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2211 MEDICINA REGENERATIVO EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2212 PARAGUAY MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2213 PARAGUAY GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2214 PARAGUAY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 2215 PARAGUAY CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2216 PARAGUAY SBS-IF MARKET ATTRIBUTABLE EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2217 PARAGUAY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 2218 PARAGUAY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2219 PARAGUAY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 2220 PARAGUAY INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2221 PARAGUAY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 2222 PARAGUAY TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 2223 USD
CUADRO 2224 REST OF SOUTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
CUADRO 2225 REST OF SOUTH AMERICA NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2226 REST OF SOUTH AMERICA PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2227 REST OF SOUTH AMERICA TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2228 REST OF SOUTH AMERICA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2229 REST OF SOUTH AMERICA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 2230 REST OF SOUTH AMERICA ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2231 TEST OF SOUTH AMERICA TUBE FEEDING IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2232 REST OF SOUTH AMERICA FORMULA TYPE IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2233 REST OF SOUTH AMERICA PN COMPOSITION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2234 REST OF SOUTH AMERICA MACRONUTRIENTS IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2235 REST OF SOUTH AMERICA MICRONUTRIENTS IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2236 REST OF SOUTH AMERICA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2237 REST OF SOUTH AMERICA HORMONAL ' INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2238 REST OF SOUTH AMERICA GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2239 REST OF SOUTH AMERICA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 2240 REST OF SOUTH AMERICA IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2241 REST OF SOUTH AMERICA ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2242 REST OF SOUTH AMERICA OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2243 REST OF SOUTH AMERICA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2244 REST OF SOUTH AMERICA PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2245 REST OF SOUTH AMERICA SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 2246 REST OF SOUTH AMERICA H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2247 REST OF SOUTH AMERICA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2248 REST OF SOUTH AMERICA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2249 REST OF SOUTH AMERICA BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2250 REST OF SOUTH AMERICA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2251 REST OF SOUTH AMERICA SURGICAS " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2252 REST OF SOUTH AMERICA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2253 REST OF SOUTH AMERICA OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2254 REST OF SOUTH AMERICA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2255 REST OF SOUTH AMERICA EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2256 REST OF SOUTH AMERICA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2257 REST OF SOUTH AMERICA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2258 REST OF SOUTH AMERICA GENE THERAPY IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2259 REST OF SOUTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 2260 REST OF SOUTH AMERICA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2261 REST OF SOUTH AMERICA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2262 REST OF SOUTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
CUADRO 2263 REST OF SOUTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2264 REST OF SOUTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 2265 REST OF SOUTH AMERICA INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2266 REST OF SOUTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 2267 REST OF SOUTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 2268 MIDDLE EAST AND AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, 2018-2033 (USD THOUSAND)
TABLE 2269 MIDDLE EAST and AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 2270 MIDDLE EAST AND AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 2271 MIDDLE EAST AND AFRICA NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2272 MIDDLE EAST AND AFRICA PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (USTED)
CUADRO 2273 MIDDLE EAST AND AFRICA TOTAL PARENTERAL NUTRITION (TPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2274 MIDDLE EAST AND AFRICA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2275 MIDDLE EAST AND AFRICA HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 2276 MIDDLE EAST AND AFRICA ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2277 MIDDLE EAST AND AFRICA TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2278 MIDDLE EAST AND AFRICA FORMULA TYPE EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2279 MIDDLE EAST AND AFRICA PN COMPOSITION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2280 MIDDLE EAST AND AFRICA MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2281 MIDDLE EAST AND AFRICA MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2282 MIDDLE EAST AND AFRICA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2283 MIDDLE EAST AND AFRICA HORMONAL & INTESTINAL ADAPTATION THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2284 EAST MIDDLE Y AFRICA GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2285 MIDDLE EAST AND AFRICA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 2286 MIDDLE EAST AND AFRICA IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2287 MIDDLE EAST AND AFRICA ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2288 MIDDLE EAST AND AFRICA OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2289 MIDDLE EAST AND AFRICA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2290 MIDDLE EAST AND AFRICA PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2291 ANÁLOGO MIDDLE EAST Y AFRICA SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME BOWEL SYNDROME CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE , 2018-2033 (USTED)
CUADRO 2292 MIDDLE EAST AND AFRICA H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2293 MIDDLE EAST AND AFRICA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2294 MIDDLE EAST AND AFRICA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2295 MIDDLE EAST AND AFRICA BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2296 MIDDLE EAST AND AFRICA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2297 MIDDLE EAST AND AFRICA SURGICAL ' INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2298 MIDDLE EAST AND AFRICA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2299 MIDDLE EAST AND AFRICA OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2300 MIDDLE EAST AND AFRICA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2301 MIDDLE EAST AND AFRICA EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2302 MIDDLE EAST AND AFRICA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2303 MIDDLE EAST AND AFRICA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2304 MIDDLE EAST AND AFRICA GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2305 MIDDLE EAST AND AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 2306 MIDDLE EAST AND AFRICA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2307 MIDDLE EAST AND AFRICA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2308 MIDDLE EAST AND AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 2309 MIDDLE EAST AND AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2310 MIDDLE EAST AND AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 2311 MIDDLE EAST AND AFRICA INTRAVENOUS IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2312 MIDDLE EAST AND AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 2313 MIDDLE EAST AND AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 2314 USD
TABLE 2315 SAUDI ARABIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 2316 SAUDI ARABIA NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2317 SAUDI ARABIA PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2318 SAUDI ARABIA TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2319 SAUDI ARABIA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2320 SAUDI ARABIA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 2321 ARABIA SAUDIO ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2322 SAUDI ARABIA TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2323 SAUDI ARABIA FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2324 SAUDI ARABIA PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2325 ARABIA SAUDIO MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2326 SAUDI ARABIA MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2327 ARABIA SAUDITA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2328 SAUDI ARABIA HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2329 ARABIA SAUDITA GLP-2 ANÁLOGO EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2330 SAUDI ARABIA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 2331 ARABIA SAUDIO IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2332 SAUDI ARABIA ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2333 SAUDI ARABIA OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2334 SAUDI ARABIA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2335 SAUDI ARABIA PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2336 ARABIA SAUDIO SOMATOSTATIN ANALOGUES EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 2337 ARABIA SAUDIO H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED)
TABLE 2338 SAUDI ARABIA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2339 SAUDI ARABIA ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2340 SAUDI ARABIA BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2341 SAUDI ARABIA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2342 SAUDI ARABIA SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2343 SAUDI ARABIA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2344 SAUDI ARABIA OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2345 SAUDI ARABIA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2346 SAUDI ARABIA EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2347 SAUDI ARABIA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2348 SAUDI ARABIA MICROBIOME-BASED THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2349 SAUDI ARABIA GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2350 ARABIA SAUDITA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, POR MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 2351 SAUDI ARABIA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2352 SAUDI ARABIA SBS-IF EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2353 SAUDI ARABIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 2354 SAUDI ARABIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2355 SAUDI ARABIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 2356 ARABIA SAUDIO INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2357 SAUDI ARABIA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 2358 ARABIA SAUDITA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 2359 USD
TABLE 2360 SOUTH AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 2361 SOUTH AFRICA NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2362 SOUTH AFRICA PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2363 SOUTH AFRICA TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2364 SOUTH AFRICA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2365 SOUTH AFRICA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
TABLE 2366 SOUTH AFRICA ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2367 SOUTH AFRICA TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2368 SOUTH AFRICA FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2369 SOUTH AFRICA PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2370 ASUNTOS SUR ÁFRICA EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2371 MICRONUTRIENTES SUR AFRICA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2372 SOUTH AFRICA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2373 SOUTH AFRICA HORMONAL & INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2374 SOUTH AFRICA GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2375 SOUTH AFRICA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
TABLE 2376 SOUTH AFRICA IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2377 SOUTH AFRICA ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2378 SOUTH AFRICA OPIOID-BASED IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2379 SOUTH AFRICA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2380 INHIBITORES SUR AFRICA PROTON EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2381 ANÁLOGO SUR ÁFRICA SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE , 2018-2033 (US$ THOUSAND)
CUADRO 2382 ANTAGONISTAS H2 SOUTH AFRICA EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2383 SUR AFRICA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2384 SOUTH AFRICA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2385 ACID SOUTH AFRICA " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2386 SOUTH AFRICA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2387 TRATAMIENTO SURGICO e INTERVENTIONAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2388 PROCEDIMIENTOS DE LENGTHENING INTESTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2389 SOUTH AFRICA OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2390 SOUTH AFRICA TRANSPLANTATION INTESTINAL IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2391 EMERGACION SUR ÁFRICA " AVANCIAS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2392 SOUTH AFRICA REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2393 SOUTH AFRICA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2394 SOUTH AFRICA GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2395 SOUTH AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 2396 SOUTH AFRICA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2397 SOUTH AFRICA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2398 SOUTH AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
CUADRO 2399 SOUTH AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2400 SOUTH AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 2401 SOUTH AFRICA INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2402 SOUTH AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 2403 SOUTH AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 2404 USD
TABLE 2405 EGIPTO TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 2406 EGIPTO NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2407 EGIPTO PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2408 EGYPT TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2409 EGIPTO HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2410 EGIPTO HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
TABLE 2411 EGIPTO ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2412 EGIPTO TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2413 EGYPT FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2414 EGIPTO PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2415 EGIPTO MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2416 EGIPTO MICRONUTRIENTS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2417 EGIPTO PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2418 EGYPT HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2419 ANALOGOS EGIPTO GLP-2 EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2420 EGYPT GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USTED)
CUADRO 2421 EGIPTO IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2422 EGYPT ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2423 EGIPTO OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2424 EGIPTO ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2425 EGIPTO PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2426 ANÁLOGO EGIPTO SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (US$ THOUSAND)
CUADRO 2427 EGIPTO H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2428 EGIPTO MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2429 EGIPTO ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2430 EGYPT BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2431 EGIPTO BILE ACID SEQUESTRANTS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2432 TREATMENTO SURGICO e INTERVENTIONAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2433 PROCEDIMIENTOS DE LENGTHENING INTESTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2434 OSTOMÍA EGIPTO " RECONSTRUCCIÓN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2435 EGIPTO TRANSPLANTACIÓN INTESTINAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2436 EGIPTO EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2437 MEDICINA REGENERATIVO DE EGIPTO EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2438 EGYPT MICROBIOME-BASED THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2439 EGYPT GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2440 EGIPTO TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 2441 EGIPTO CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2442 EGIPTO SBS-IF MARKET ATTRIBUTABLE EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2443 EGIPTO TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 2444 EGIPTO TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2445 EGIPTO TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 2446 EGIPTO INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2447 EGIPTO TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 2448 EGIPTO TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 2449 USD
TABLE 2450 ISRAEL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 2451 ISRAEL NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2452 ISRAEL PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2453 ISRAEL TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2454 ISRAEL HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2455 ISRAEL HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 2456 ISRAEL ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2457 ISRAEL TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2458 ISRAEL FORMULA TYPE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2459 COMPOSICIÓN DE PN ISRAEL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2460 ISRAEL MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2461 MICRONUTRIENTS ISRAEL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2462 ISRAEL PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2463 ISRAEL HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2464 ISRAEL GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2465 ISRAEL GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USTED)
CUADRO 2466 ISRAEL IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2467 ISRAEL ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2468 ISRAEL OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2469 ISRAEL ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2470 ISRAEL PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2471 ANÁLOGO SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE , 2018-2033 (US$ THOUSAND)
CUADRO 2472 ISRAEL H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2473 APLICACIÓN MICRONUTRIENTE ISRAEL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED THOUSAND)
TABLE 2474 ISRAEL ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2475 ACID de ISRAEL & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2476 SEQUESTRANTES DE IRAEL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2477 TREATMENTO SURGICO " INTERVENTIONAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2478 PROCEDIMIENTOS INTESTINALES DE LENGTHENING EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2479 OSTOMÍA DE ISRAEL " RECONSTRUCCIÓN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2480 ISRAEL INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2481 EMERGACIÓN DE ISRAEL " AVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2482 ISRAEL REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2483 ISRAEL MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2484 ISRAEL GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2485 ISRAEL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 2486 CORE ISRAEL SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2487 ISRAEL SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2488 ISRAEL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 2489 ISRAEL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2490 ISRAEL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 2491 ISRAEL INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2492 ISRAEL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 2493 ISRAEL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 2494 USD
CUADRO 2495 EMIRATES DE LAS NACIONES UNIDAS TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
CUADRO 2496 EMIRATES DE ARAB NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2497 EMIRATES PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2498 EMIRATES DE LAS NACIONES UNIDAS DE ARAB TOTAL PARENTERAL NUTRITION (TPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (USTED)
CUADRO 2499 EMIRATOS ÁRABES DE LAS NACIONES UNIDAS INICIO PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2500 EMIRATES ÁRABES INICIO PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 2501 EMIRATES ÁRABES ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2502 UNITED ARAB EMIRATES TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2503 EMIRATES DE LAS NACIONES UNIDAS PARAMULA TYPE EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2504 UNITED ARAB EMIRATES PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2505 EMIRATES DE LAS NACIONES UNIDAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2506 MICRONUTRIENTES DE LAS NACIONES UNIDAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2507 EMIRATES DE ÁRABES PHARMACOLOGICA EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2508 EMIRATES ÁRABES HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2509 EMIRATOS ÁRABES GLP-2 ANÁLOGO EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2510 EMIRATES DE ARAB GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 2511 EMIRATES DE ÁRABES IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2512 EMIRATES ÁRABES ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2513 EMIRATES ÁRABES OPIOID-BASED EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2514 EMIRATES ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2515 EMIRATOS ÁRABES PROTONES PUMP INHIBITORS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2516 EMIRATOS ÁRABES SOMATOSTATIN ANALOGUES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 2517 EMIRATES H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2518 EMIRATES MICRONUTRIENT SUPPLEMENTATION EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2519 EMIRATES ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2520 EMIRATES ÁRABES DE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL con FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED)
CUADRO 2521 EMIRATOS ÁRABES BILES ACID SEQUESTRANTES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2522 EMIRATOS ÁRABES SURGICOS " INTERVENTIONAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (USTED THOUSAND)
CUADRO 2523 EMIRATOS ÁRABES DE LAS NACIONES UNIDAS PROCEDIMIENTOS DE LENGTHENING INTESTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (USTED THOUSAND)
CUADRO 2524 EMIRATES DE LA OSTOMÍA " RECONSTRUCCIÓN EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2525 EMIRATES DE LAS NACIONES UNIDAS EN TRANSPLANTACIÓN INTESTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2526 EMIRATES DE LAS NACIONES UNIDAS EN TYPE 1 SBS-IF (SYNDROME BOWEL SYNDROME CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (USTED THOUSAND)
CUADRO 2527 EMIRATES REGENERATIVE MEDICINE EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2528 EMIRATES ÁRABES MICROBIOME-BASED THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (USTED)
TABLE 2529 UNITED ARAB EMIRATES GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2530 EMIRATES DE ARAB TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 2531 EMIRATOS ÁRABES DE CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED)
CUADRO 2532 EMIRATES DE ÁRABES SBS-IF MARKET ATTRIBUTABLE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED)
CUADRO 2533 EMIRATES DE ARAB TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
CUADRO 2534 EMIRATES DE LAS NACIONES UNIDAS TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2535 EMIRATES DE LAS NACIONES UNIDAS TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 2536 EMIRATES DE LAS NACIONES UNIDAS EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2537 EMIRATES DE LAS NACIONES UNIDAS TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 2538 EMIRATES DE ARAB TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 2539 USD
CUADRO 2540 KUWAIT TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
CUADRO 2541 KUWAIT NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2542 KUWAIT PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2543 KUWAIT TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2544 KUWAIT HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2545 KUWAIT HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 2546 KUWAIT ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED THOUSAND)
TABLE 2547 KUWAIT TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2548 KUWAIT FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2549 KUWAIT PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2550 KUWAIT MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2551 KUWAIT MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2552 KUWAIT PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2553 KUWAIT HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2554 KUWAIT GLP-2 ANALOGUES EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2555 KUWAIT GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USTED)
CUADRO 2556 KUWAIT IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2557 KUWAIT ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2558 KUWAIT OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2559 KUWAIT ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2560 KUWAIT PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2561 KUWAIT SOMATOSTATIN ANALOGUES EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 2562 KUWAIT H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2563 KUWAIT MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2564 KUWAIT ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2565 KUWAIT BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2566 KUWAIT BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2567 KUWAIT SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2568 KUWAIT INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2569 KUWAIT OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2570 KUWAIT INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2571 KUWAIT EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2572 KUWAIT REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2573 KUWAIT MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2574 KUWAIT GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2575 KUWAIT TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 2576 KUWAIT CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2577 KUWAIT SBS-IF MARKET ATTRIBUTABLE EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2578 KUWAIT TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 2579 KUWAIT TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2580 KUWAIT TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 2581 KUWAIT INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2582 KUWAIT TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 2583 KUWAIT TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 2584 USD
TABLE 2585 TYPE OMAN 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
CUADRO 2586 OMAN NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED THOUSAND)
CUADRO 2587 DE PARENTERAL OMAN NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2588 OMAN TOTAL PARENTERAL NUTRITION (TPN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2589 OMAN HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2590 OMAN HOME PARENTERAL NUTRITION (HPN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 2591 NUTRICIÓN ENTERAL OMAN (EN) EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2592 OMAN TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2593 OMAN FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2594 PN COMPOSICIÓN OMAN EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2595 MACRONUTRIENTS OMAN EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2596 MICRONUTRIENTS OMAN EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2597 OMAN PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2598 OMAN HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2599 ANALOGOS OMAN GLP-2 EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2600 OMAN GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED, 2018-2033 (USD THOUSAND)
TABLE 2601 OMAN IGF-1 & ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2602 ANTI-DIARRHEAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2603 OMAN OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2604 ANTI-SECRETORY THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2605 INHIBIdores OMAN PROTON PUMP EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2606 ANÁLOGO OMAN SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USTED THOUSAND)
CUADRO 2607 ANTAGONISTAS OMAN H2 RECEPTOR EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2608 SUPLEMENTO OMAN MICRONUTRIENT EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2609 OMAN ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2610 MODIFICADORES DE ACID DE ABSORPCIÓN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2611 SEQUESTRANTES OMAN BILE ACID EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2612 TREATMENTO SURGICANO OMAN " INTERVENTIONAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2613 PROCEDIMIENTOS DE LENGTHENING OMAN INTESTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2614 OMAN OSTOMY " RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2615 TRANSPLANTACIÓN INTESTINAL OMAN EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2616 OMAN EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2617 OMAN REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2618 OMAN MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2619 OMAN GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2620 OMAN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 2621 OMAN CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2622 OMAN SBS-IF ATRIBUTABLE MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2623 OMAN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 2624 OMAN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2625 OMAN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 2626 OMAN INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2627 OMAN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 2628 OMAN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 2629 USD
CUADRO 2630 QATAR TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 2631 QATAR NUTRITIONAL SUPPORT THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2632 QATAR PARENTERAL NUTRITION (PN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2633 QATAR TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2634 QATAR HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2635 QATAR HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 2636 NUTRICIÓN ENTERAL QATAR (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2637 QATAR TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2638 QATAR FORMULA TYPE EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2639 QATAR PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2640 QATAR MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2641 MICRONUTRIENTS QATAR EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2642 QATAR PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2643 QATAR HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2644 ANALOGOS QATAR GLP-2 en TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2645 QATAR GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 2646 QATAR IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2647 QATAR ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2648 QATAR OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2649 QATAR ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2650 QATAR PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2651 ANÁLOGO DE SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE , 2018-2033 (US$ THOUSAND)
TABLE 2652 QATAR H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2653 QATAR MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2654 QATAR ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2655 QATAR BILE ACID & ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2656 QATAR BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2657 TREATMENTO SURGICO " INTERVENTIONAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2658 PROCEDIMIENTOS INTESTINALES DE LENGTHENING EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2659 OSTOMÍA QATAR " RECONSTRUCCIÓN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2660 QATAR INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2661 QATAR EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2662 QATAR REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2663 QATAR MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2664 QATAR GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2665 QATAR TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 2666 QATAR CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2667 QATAR SBS-IF MARKET ATTRIBUTABLE EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2668 QATAR TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 2669 QATAR TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2670 QATAR TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 2671 QATAR INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2672 QATAR TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 2673 QATAR TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 2674 USD
TABLE 2675 BAHRAIN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
TABLE 2676 BAHRAIN NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2677 BAHRAIN PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2678 BAHRAIN TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2679 BAHRAIN HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2680 BAHRAIN HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 2681 BAHRAIN ENTERAL NUTRITION (EN) EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2682 BAHRAIN TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2683 BAHRAIN FORMULA TYPE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2684 BAHRAIN PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2685 MACRONUTRIENTES BAHRAIN EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2686 MICRONUTRIENTES BAHRAIN EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2687 BAHRAIN PHARMACOLOGICAL THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2688 BAHRAIN HORMONAL " INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2689 ANALOGOS BAHRAIN GLP-2 EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE, 2018-2033 (USTED THOUSAND)
TABLE 2690 BAHRAIN GROWTH HORMONE THERAPY EN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 2691 BAHRAIN IGF-1 " ANALOGUES IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2692 BAHRAIN ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2693 BAHRAIN OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2694 BAHRAIN ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2695 BAHRAIN PROTON PUMP INHIBITORS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2696 ANÁLOGO BAHRAIN SOMATOSTATIN EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT CON FAILURE INTESTINAL) TREATMENT MARKET, POR TYPE , 2018-2033 (US$ THOUSAND)
CUADRO 2697 BAHRAIN H2 RECEPTOR ANTAGONISTAS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
TABLE 2698 BAHRAIN MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SYNDROME BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2699 ANTI-INFECTIVE THERAPY EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2700 BAHRAIN BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2701 BAHRAIN BILE ACID SEQUESTRANTS EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2702 TRATAMIENTO SURGICO " INTERVENTIONAL EN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2703 PROCEDIMIENTOS DE LENGTHENING INTESTINAL EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT con FAILURE INTESTINAL) TREATMENT MARKET, BY TYPE, 2018-2033 (USTED)
CUADRO 2704 BAHRAIN OSTOMY " RECONSTRUCTION IN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2705 BAHRAIN INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2706 BAHRAIN EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2707 BAHRAIN REGENERATIVE MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2708 BAHRAIN MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2709 BAHRAIN GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2710 BAHRAIN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
CUADRO 2711 BAHRAIN CORE SBS-IF MARKET EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (US$ THOUSAND)
CUADRO 2712 BAHRAIN SBS-IF MARKET ATTRIBUTABLE EN TYPE 1 SBS-IF (SYNDROME DE BOWEL SHORT with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2713 BAHRAIN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
TABLE 2714 BAHRAIN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2715 BAHRAIN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 2716 BAHRAIN INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2717 BAHRAIN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 2718 BAHRAIN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
CUADRO 2719 USD
TABLE 2720 REST OF MIDDLE EAST AND AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY, 2018-2033 (USD THOUSAND)
CUADRO 2721 REST OF MIDDLE EAST AND AFRICA NUTRITIONAL SUPPORT THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2722 REST OF MIDDLE EAST AND AFRICA PARENTERAL NUTRITION (PN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2723 REST OF MIDDLE EAST AND AFRICA TOTAL PARENTERAL NUTRITION (TPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2724 REST OF MIDDLE EAST AND AFRICA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2725 REST OF MIDDLE EAST AND AFRICA HOME PARENTERAL NUTRITION (HPN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT DURATION, 2018-2033 (USD THOUSAND)
CUADRO 2726 REST OF MIDDLE EAST AND AFRICA ENTERAL NUTRITION (EN) IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2727 REST OF MIDDLE EAST AND AFRICA TUBE FEEDING IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2728 REST OF MIDDLE EAST AND AFRICA FORMULA TYPE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2729 REST OF MIDDLE EAST AND AFRICA PN COMPOSITION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2730 REST OF MIDDLE EAST AND AFRICA MACRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2731 REST OF MIDDLE EAST AND AFRICA MICRONUTRIENTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2732 REST OF MIDDLE EAST AND AFRICA PHARMACOLOGICAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2733 REST OF MIDDLE EAST AND AFRICA HORMONAL ' INTESTINAL ADAPTATION THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2734 REST OF MIDDLE EAST AND AFRICA GLP-2 ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2735 REST OF MIDDLE EAST AND AFRICA GROWTH HORMONE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY SOMATROPIN-BASED , 2018-2033 (USD THOUSAND)
CUADRO 2736 REST OF MIDDLE EAST AND AFRICA IGF-1 ' ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2737 REST OF MIDDLE EAST AND AFRICA ANTI-DIARRHEAL THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2738 REST OF MIDDLE EAST AND AFRICA OPIOID-BASED IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2739 REST OF MIDDLE EAST AND AFRICA ANTI-SECRETORY THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2740 REST OF MIDDLE EAST AND AFRICA PROTON PUMP INHIBITORS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2741 REST OF MIDDLE EAST AND AFRICA SOMATOSTATIN ANALOGUES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE , 2018-2033 (USD THOUSAND)
CUADRO 2742 REST OF MIDDLE EAST AND AFRICA H2 RECEPTOR ANTAGONISTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2743 REST OF MIDDLE EAST AND AFRICA MICRONUTRIENT SUPPLEMENTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2744 REST OF MIDDLE EAST AND AFRICA ANTI-INFECTIVE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2745 REST OF MIDDLE EAST AND AFRICA BILE ACID " ABSORPTION MODIFIERS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2746 REST OF MIDDLE EAST AND AFRICA BILE ACID SEQUESTRANTS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2747 REST OF MIDDLE EAST AND AFRICA SURGICAL " INTERVENTIONAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2748 REST OF MIDDLE EAST AND AFRICA INTESTINAL LENGTHENING PROCEDURES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2749 REST OF MIDDLE EAST AND AFRICA OSTOMY ' RECONSTRUCTION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2750 REST OF MIDDLE EAST AND AFRICA INTESTINAL TRANSPLANTATION IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2751 REST OF MIDDLE EAST AND AFRICA EMERGING " ADVANCED THERAPIES IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2752 REST OF MIDDLE EAST AND AFRICA REGENERA MEDICINE IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2753 REST OF MIDDLE EAST AND AFRICA MICROBIOME-BASED THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2754 REST OF MIDDLE EAST AND AFRICA GENE THERAPY IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2755 REST OF MIDDLE EAST AND AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY MARKET ATTRIBUTION, 2018-2033 (USD THOUSAND)
TABLE 2756 REST OF MIDDLE EAST AND AFRICA CORE SBS-IF MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 2757 REST OF MIDDLE EAST AND AFRICA SBS-IF ATTRIBUTABLE MARKET IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2758 REST OF MIDDLE EAST AND AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISEASE MANAGEMENT PHASE, 2018-2033 (USD THOUSAND)
CUADRO 2759 REST OF MIDDLE EAST AND AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY PATIENT TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2760 REST OF MIDDLE EAST AND AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
CUADRO 2761 REST OF MIDDLE EAST AND AFRICA INTRAVENOUS IN TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
CUADRO 2762 REST OF MIDDLE EAST AND AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY END USER, 2018-2033 (USD THOUSAND)
CUADRO 2763 REST OF MIDDLE EAST AND AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
Lista de figuras
FIGURE 1 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: SEGMENTATION
FIGURE 2 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 8 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: MULTIVARIVATE MODELING
FIGURE 10 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: PRODUCT TYPE TIMELINE CURVE
FIGURE 11 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: APPLICATION COVERAGE GRID
FIGURE 12 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: SEGMENTATION
FIGURE 13 FOUR SEGMENTS COMPRISE THE GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET, BY TREATMENT MODALITY (2025)
FIGURE 14 NORTH AMERICA IS EXPECTED TO BE THE DOMINANT AND ASIA-PACIFIC IS THE FASTEST GRWOING REGION IN THE GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET IN THE FORECAST PERIOD of 2026 TO 2033
FIGURE 15 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: EXECUTIVE SUMMARY
FIGURE 16 RISING SBS-IF PATIENT POPULATION IS EXPECTED TO DRIVE THE GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET DURING THE FORECAST PERIOD OF 2026 TO 2033.
FIGURE 17 NUTRITIONAL SUPPORT THERAPY is EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET IN 2026 & 2033
FIGURE 18 DECISIONES ESTRATEGICAS
FIGURE 19 SIA-PACIFIC THE FASTEST-GROWING REGION FOR THE GLOBAL TYPE 1 SBS-IF (SYNDROME BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET IN THE FORECAST PERIOD of 2026 TO 2033
FIGURE 20 PESTEL ANALISIS
21 ANALISIS DE DROC
FIGURE 22 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: BY TREATMENT MODALITY, 2025
FIGURE 23 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: BY MARKET ATTRIBUTION, 2025
FIGURE 24 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: BY DISEASE MANAGEMENT PHASE, 2025
FIGURE 25 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: BY PATIENT TYPE, 2025
FIGURE 26 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2025
FIGURE 27 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: BY END USER, 2025
FIGURE 28 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2025
FIGURE 29 GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: SNAPSHOT (2025)
FIGURE 30 NORTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: SNAPSHOT (2025)
FIGURE 31 EUROPE TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: SNAPSHOT (2025)
FIGURE 32 ASIA-PACIFIC TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: SNAPSHOT (2025)
FIGURE 33 SOUTH AMERICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: SNAPSHOT (2025)
FIGURE 34 MIDDLE EAST AND AFRICA TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: SNAPSHOT (2025)
FIGURE 35 GLOBAL GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: COMPANY SHARE 2025 (%)
FIGURE 36 ASIA-PACIFIC GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: COMPANY SHARE 2025 (%)
FIGURE 37 EUROPE GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: COMPANY SHARE 2025 (%)
FIGURE 38 NORTH AMERICA GLOBAL TYPE 1 SBS-IF (SHORT BOWEL SYNDROME with INTESTINAL FAILURE) TREATMENT MARKET: COMPANY SHARE 2025 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
